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ABSTRACT
Human noroviruses (HNoVs) are considered the leading cause of acute non-bacterial
gastroenteritis worldwide. Effective chemical disinfectants to inactivate HNoVs are needed.
Since HNoVs cannot be cultivated in the lab, cultivable surrogates, feline calicivirus (FCV-F9)
and murine norovirus (MNV-1), are used to determine inactivation using infectivity plaque
assays. This study aimed to: 1) determine the ability of benzalkonium chloride (BAC) and
potassium peroxymonosulfate (KPMS) to inactivate FCV-F9 and MNV-1 in vitro using
suspension and carrier tests under clean and simulated dirty (5% fetal bovine serum) conditions
over 1 h at room temperature; 2) determine inactivation of FCV-F9 and MNV-1 in suspension
and carrier tests over 1 h at room temperature by sodium metasilicate (SMS). In suspension tests,
BAC caused 1.94 and 2.59 log reductions of low and high FCV-F9 titers after 1 h, respectively.
MNV-1 at low and high titers was reduced by > 3 and 1.47 logs with BAC after 1 h, respectively.
KPMS at 5 and 10 mg/mL reduced low titers of both viruses to non-detectable levels within 30 s.
High FCV-F9 titers were non-detectable after 2 min with 5 mg/mL and within 30 s with 10
mg/mL of KPMS. KPMS at 5 mg/mL had little effect against high titers of MNV-1, but caused a
4.61 log reduction after 5 min with 10 mg/mL of KPMS. Using clean carrier tests, KPMS at 5
and 10 mg/mL reduced both tested viruses at low titers after 30 s and only high FCV-F9 titers
after 10 min to undetectable levels. MNV-1 at high titers were reduced to non-detectable levels
after 15 min with 10 mg/mL KPMS. BAC reduced low titers of both viruses to undetectable
levels after 1 h using carrier tests with no significant reduction of high titers even after 2 h. The
antiviral effect of both chemicals decreased under simulated dirty conditions. Both viruses were
reduced within 15 s by 5% and 10% SMS using suspension tests. FCV-F9 and MNV-1 at high
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titers were reduced to undetectable levels after 2 min and 15 s, respectively with 2% SMS.
KPMS and SMS appear suitable for the rapid control of HNoV transmission.
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CHAPTER I
LITERATURE REVIEW

Introduction
Foodborne illnesses are regarded as leading public health concerns worldwide as causes
of morbidity and mortality. It is estimated that foodborne diseases cause approximately 9.4
million illnesses, 55961 hospitalizations, and 1351 deaths in the United States each year
associated with 31 known pathogens (Scallan et al., 2011). The causative agents of foodborne
illness include viruses, bacteria, parasites, toxins, metals, and prions (Mead et al., 1999). Among
them, viruses are currently considered the leading cause of foodborne illnesses, responsible for
59% (5.5 million) of foodborne disease cases (Scallan et al., 2011).
Enteric viruses that can be transmitted by foodborne or waterborne routes include human
caliciviruses (noroviruses, sapoviruses, vesiviruses and lagoviruses), hepatitis A and E virus,
human enteroviruses (poliovirus, coxsackie A and B, echovirus, enterovirus serotypes 68-71),
astroviruses, other small round viruses, parvoviruses, and rotavirus (Sair et al., 2002). From an
epidemiological perspective, the agents that are responsible for the most common cause of acute
viral gastroenteritis around the world are human noroviruses. Current estimates are that human
noroviruses are responsible for approximately 3.2 million (58%) illnesses, 14,550 (26%)
hospitalizations and 287 (11%) deaths annually in the U.S. alone (Scallan et al., 2011). However,
these figures can be considered as an underestimate due to the disease being under-reported and
cases frequently undetected or outbreaks being uninvestigated. Therefore, it is imperative to
develop effective inactivation strategies to control human norovirus spread and prevent their
outbreaks in food processing and nosocomial environments.
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Human Norovirus and its Surrogates
Human norovirus was first discovered by Albert Kapikian in 1972 using immune electron
microscopy (IEM) of stool samples collected from a 1968 outbreak of gastroenteritis in Norwalk,
Ohio, USA (Kapikian et al., 1972). Since then, the so-called “Norwalk virus” began to be
significantly recognized. Norovirus, the prototype member of small round structured viruses
(SRSVs), belongs to the family Caliciviridae based on the genetic sequencing work (Jiang et al.,
1993; Xi et al., 1990). Currently, this family is comprised of four genera: noroviruses
(represented by Norwalk-like viruses, having Norwalk virus prototype strain), sapoviruses
(represented by Sapporo-like viruses, having Sapporo virus prototype strain), vesiviruses
(represented by vesicular exanthema of swine virus and feline calicivirus) and lagoviruses
(represented by rabbit hemorrhagic disease virus and European brown hare syndrome virus), the
former two genera being significant to human epidemic gastroenteritis (D’Souza et al., 2007;
Sair et al., 2002).
The genus norovirus is comprised of a genetically diverse group of non-enveloped,
single-stranded, positive sense RNA viruses. These viruses are icosahedral in shape with a
diameter of 27 to 35 nm; and buoyant density of 1.33-1.41 g/cm3 in CsCl (Kapikian et al., 1972).
The norovirus capsid protein consists of 180 capsid protein molecules possessing a molecular
weight ranging from 59,000 to 65,000 Da (Jiang et al., 1993; Kapikian et al., 1996). The
norovirus genome consists of three open reading frames (ORF) to encode structural and nonstructural proteins. ORF1 possesses the longest nucleotides and encodes the non-structural
proteins (RNA dependent RNA polymerase); ORF2 encodes the viral capsid protein; and ORF3
encodes a small polypeptide conjectured to package the genome into virions (Donaldson et al.,
2008; Jiang et al., 1993).
2

Based on the sequencing analysis of the RNA-dependent RNA polymerase region and
capsid protein region, noroviruses are classified into five genogroups. Genogroups (G) I, GII and
GIV are associated with human infections and responsible for foodborne illness outbreaks; they
are represented by the prototype Norwalk virus, prototype Snow Mountain agent and prototype
Ft. Lauderdale virus, respectively. The other genogroups, GIII and GV are associated with animal
infections, represented by prototype, bovine enteric calicivirus and prototype murine norovirus,
respectively (D’Souza et al., 2007). Among human infecting genogroups, GII is predominant,

responsible for the most human norovirus outbreaks. As reported previously, approximately 73%
of human norovirus illnesses are caused by GII viruses (Zheng et al., 2006). The emerging of
virulent strains including GII.4 can cause deaths in the elderly and immune-compromised
(Siebenga et al., 2010). Norovirus genogroups can be further subdivided into genotypes, also known
as genoclusters. Currently, GI is comprised of eight genotypes and GII has at least seventeen
genotypes (Zheng et al., 2006).

Human noroviruses, in a similar manner to other enteric viruses, can be transmitted by the
fecal-oral route or by direct contact with an infected person as well as by consuming
contaminated food or water or touching contaminated surfaces (Kukkula et al., 1999; Weinstein
et al., 2008). Aerosolized vomitus is another transmission mode for human noroviruses
(Patterson et al., 1997). The difficulty in controlling the spread of human noroviruses is due to
their high primary and secondary attack rate, environmental stability and low infectious dose
(Caul, 1994; D’Souza et al., 2006; Liu et al., 2009). Outbreaks associated with human
noroviruses have occurred in a variety of closed settings, including healthcare facilities,
restaurants, cruise ships, schools, hotels, and other institutional settings (CDC, 2011), as
evidenced by the environmental persistence of human noroviruses. Further, the survival of
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human noroviruses in human gastrointestinal tract indicates their persistence in the presence of
degrading enzymes and extreme pH environments (Sair et al., 2002). Previous studies have
shown that human noroviruses can be detected on food-contact surfaces for up to 7 days at room
temperature; can persist at temperatures ranging from freezing to 60oC (30 min); at pH 2.7 for 3
h at room temperature in stool; with treatment of 20% ether for 18 h at 4oC; and resistant to low
concentrations of chlorine (3.75-6.25 mg/L) (D'Souza et al., 2006; D’Souza et al., 2007; Dolin et
al., 1972; Patel et al., 2009; Teunis et al., 2008). The infectious dose of human noroviruses is
quite low; only 10 infectious units can cause disease. The incubation period of human norovirus
infection is typically 12-48 h and characterized by mild to severe gastroenteritis with symptoms
include vomiting, nausea, diarrhea, and abdominal pain. The duration of the infection may last
12-72 h; however, fecal viral shedding can be extended for several more days (Grohmann et al.,
1981; Cliver et al., 2002; D’Souza et al., 2007). Although, HNoV infection itself is self-limiting
in healthy individuals, they can be life-threatening to the elderly and immune-compromised
(Donaldson et al., 2010; Siebenga et al., 2009).
To date, the major hurdle for gaining a better knowledge of human noroviruses lies in the
fact that human noroviruses cannot be cultivated in cell culture. Therefore, cultivable surrogates
are needed to study the basic pathology of human noroviruses, explore the environmental
stability of these viruses and determine the efficacy of various control strategies. Several
cultivable enteric caliciviruses within the Caliciviridae family have been utilized as human
norovirus surrogates, including feline calicivirus (FCV-F9), murine norovirus (MNV-1), canine
calicivirus (a vesivirus) (Mochizuki et al., 1993), Tulane virus (Farkas et al., 2008) and porcine
enteric calicivirus (a sapovirus) (Guo et al., 1999). Currently, the most widely used surrogates
are FCV-F9 and MNV-1, which are genetically similar to norovirus because they all belong to
4

the Caliciviridae family. FCV-F9 is positioned in the Vesivirus genus, causing acute oral and
upper respiratory tract disease in feline populations, typically cats (Green et al., 2000; Radford et
al., 2007). This virus has been extensively utilized as a surrogate for human norovirus as a model
of evaluating viral persistence and reduction due to its ease of culture and quantification.
However, unlike human norovirus, FCV-F9 is transmitted by the respiratory instead of the fecaloral route (Green et al., 2001). Further, this virus is more vulnerable to environmental stresses,
being sensitive to low pH and elevated temperatures as well as chemical treatments (D'Souza and
Su, 2010; Doultree et al., 1999; Slomka and Appleton, 1998). MNV-1, a recently cultivable
surrogate for human norovirus, belongs to the Norovirus genus, which indicates more
morphological and genetic similarity to human noroviruses; this virus is currently the only
norovirus known in literature that is amenable to cell culture (Wobus et al., 2006). MNV-1 can
infect and replicate in mice. Like human norovirus, this virus is transmitted via the fecal-oral
route. Further, MNV-1 shares many biochemical and genetic characteristics with human strains,
including size, shape and buoyant density (Wobus et al., 2006). With such similarities, MNV-1
shows considerable promise as a surrogate for human noroviruses. However, there are
differences. MNV-1 binds to sialic acid on the host cell surface as a receptor, while human
norovirus recognizes the histoblood group antigens (HBGAs) (Taube et al., 2009); and the two
viruses have different clinical manifestations for MNV-1 does not cause diarrhea or vomiting
(Karst et al., 2003). Thus, an effective animal model is still being investigated. Recently, Tulane
Virus has been cultivated in the laboratory and is considered an alternate surrogate to MNV-1 by
some investigators (Li et al., 2012; Tan and Jiang, 2010). This enteric virus was isolated from
stool samples of captive juvenile rhesus macaques, which can replicate in vitro in monkey cell
lines (Farkas et al., 2008). Tulane virus has a diameter of 36 nm and a buoyant density of 1.37
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g/mL; and most importantly, this virus recognizes human HBGAs as a receptor (Farkas et al.,
2010). However, Tulane virus belongs to a new calicivirus genus separate from
the Norovirus genus and the pathogenicity of Tulane virus in rhesus macaques remains unknown
(Farkas et al., 2008). Further, Hirneisen and Kniel compared the behavior of MNV-1 and Tulane
virus and concluded that MNV-1 is a better surrogate for HNoV, as MNV-1 is more pH (2.0 to
10.0) stable, more resistant to chlorine treatment at 2 ppm and more persistent in tap water at 4
o

C (Hirneisen and Kniel, 2013). Overall, the infectivity studies of surrogates can be used to gain

a better understanding of human noroviruses; however, they cannot always model human strains.
Hence, it is necessary to use caution when interpreting the results of surrogates. Feeding and
challenge studies are deemed more suitable by some investigators.
Chemical Inactivation of Human Norovirus surrogates
To control the spread of human noroviruses and their emerging virulent forms, control
strategies have been evaluated including heat inactivation, non-thermal methods, chemical and
natural bioactives as alternates. Since human noroviruses can be transmitted via the fecal-oral
route, human excretions including stool and vomit can be the main source of human norovirus
environmental transmission. The titer of viral particle shed in the feces can be as high as 108 /g
(Atmar et al., 2008). Therefore, it is imperative to implement control measures to interrupt the
transmission of human noroviruses. The use of chemical disinfectants can be considered as an
effective intervention strategy to prevent transmission of human noroviruses from contaminated
surfaces (Barker et al., 2004).
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Chlorine:
Chlorine is an important chemical applied as a disinfectant to kill microorganisms in
drinking water and swimming pools. Chlorine is the active ingredient of store-bought household
bleach, which normally contains 5.7% available chlorine. The dosage typically used is 4 ppm for
disinfecting water.
The antiviral activity of free chlorine is proposed to occur by damaging the capsid as well
as RNA (McDonnell and Russell, 1999). Li and others (2002) reported that chlorine at 10 or 20
mg/L concentration could completely inactivate hepatitis A virus (HAV) after 30 min of
exposure in a cell culture model. Using an enzyme-linked immunosorbent assay, the
disappearance of antigenicity was observed after chlorine treatment/inactivation, which indicates
that chlorine may target nucleic acids rather than capsid proteins. It was reported that the
inactivation of HAV was due to the damage of the 5’ nontranslated regions (5’NTR), as
evaluated by long-overlap RT-PCR (Li et al., 2002). Furthermore, Baert and others (2009)
suggested that FCV, MS2 and HAV react similarly to chlorine because a similar decline was
observed among FCV, MS2 and HAV (Baert et al., 2009). Allwood and others (2004) observed
2.9 log reductions of both FCV and MS2 on leafy vegetables treated with 200 ppm chlorine after
2 min of exposure (Allwood et al., 2004). Similarly, Casteel and others (2008) found that
produce treated with 20 ppm chlorine for 10 min enabled a reduction of at least 1.7 log PFU/mL
HAV and MS2 (Casteel et al., 2008).
Chlorine was found to be effective against viruses based on the dose, contact time, and
the type of viruses (Table 1.1). FCV was reduced by 2.9 log10 PFU/mL on lettuce after a 2 min
treatment with 15 ppm chlorine, while MNV-1 was reduced by 1.4 log10 PFU/mL under the same
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experimental conditions (Fraisse et al., 2011). Chlorine at 200 ppm reduced FCV-F9 at low titers
(~5 log PFU/mL) on produce to undetectable levels after a short contact time of 15 s or 30 s, but
only ≤1.4 log reduction of high titers (~7 log PFU/mL) (Su and D’Souza, 2011). MNV-1 reached
lower reductions compared to FCV-F9 at both low and high titers under the same treatment and
contact time with a 2~3 log-PFU reduction and <1.3 log-PFU reduction, respectively (Su and
D’Souza, 2011). Using a surface test, 5000 ppm of chlorine was found to almost completely
inactivate FCV-F9 at both low titers (~5 log PFU/mL) and high titers (~7 log PFU/mL) after 30 s
or 1 min contact time, respectively at room temperature (D’Souza and Su, 2010). Duizer and
others (2004) suggested that chlorine at concentration of ≥3000 ppm could completely inactivate
FCV-F9 after a 10 min exposure at room temperature (Duizer et al., 2004). Kitajima and others
(2010) found that MNV-1 was inactivated by more than 4 logs after 120 min and 0.5 min contact
time with initial free chlorine concentration of 0.1 and 0.5 mg/L, respectively (Kitajima et al.,
2010). The findings were similar with Belliot and others (2008), with inactivation of MNV-1 by
>4 log after treatment with 0.26% chlorine after a 0.5 min contact time (Belliot et al., 2008).
Using a suspension test, 0.3 ppm of free chlorine was found to reduce partially purified FCV-F9
by >4.6 logs after a 5 min exposure (Urakami et al., 2007). However, Doultree and others (1999)
observed a 5 log reduction in the infectivity of FCV-F9 after 1 min of exposure to a
concentration of 5000 ppm free chlorine (Doultree et al., 1999). It is generally recognized that
relatively higher concentrations of chlorine are needed to inactivate human norovirus surrogates
on the surfaces. For example, Whitehead and McCue (2010) found that FCV-F9 with 100 ppm
chlorine for 1 min resulted in <2.3 log reduction, but was reduced by >3 log with 1,000 ppm
chlorine after the same exposure time (Whitehead and McCue, 2010). The results were similar to
the reports by Jimenez and Chiang (2006). They observed a 3.2 log reduction treated by 100 ppm

8

chlorine and a 6.6 log reduction by 1,000 ppm chlorine after 10 min (Jimenez and Chiang, 2006).
Gulati and others (2001) reported that, after a range of 1-10 min of exposure to different
concentrations of chlorine, a <1 log reduction was observed by <800 ppm chlorine, while a 3.4
log reduction with 5000 ppm chlorine was observed (Gulati et al., 2001). Similarly, Doultree and
others (1999) found that <500 ppm and 5000 ppm of chlorine resulted in a <3 log and 5 log
reduction, respectively after 1 min of contact time (Doultree et al., 1999). Fewer studies have
been conducted with MNV-1. Girard and others (2010) observed that MNV-1 was completely
inactivated by 3000 ppm free chlorine after both 5 min and 10 min exposure, as determined by
infectivity assay, but with a 4 log reduction using real time RT-PCR (Girard et al., 2010).
It is believed that the effect of chlorine on inactivating human norovirus surrogates is
readily decreased by organic matter. For instance, Poschetto and others (2007) observed that
FCV-F9 was reduced by >5 log with 4500-5000 ppm of free chlorine after 15 min contact time
without feces, while with feces, a 4 log reduction was observed with 5500 ppm after the same
exposure time (Poschetto et al., 2007).
Although chlorine is effective against viruses, it may create harmful disinfection byproducts including trihalomethanes, which is dangerous to life and health, and produces
unfavorable sensory effects. Chlorine can also bleach food and carcinogenic byproducts can be
formed by the interaction of chlorine with organic matter (Dunnick and Melnick, 1993). Hence,
alternate disinfectant methods are being sought.
Alcohols:
Ethanol is a commonly employed sanitizer and disinfectant used in the general
concentration range of 70%-75%. The mechanism of its antiviral activity is proposed to occur by
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denaturing capsid proteins and dissolving the lipids of the enveloped viruses (McDonnell and
Russell, 1999). Ethanol at 70% concentration has been evaluated most frequently by
investigators for its efficacy against human norovirus surrogates. However, no conclusive
suggestions/recommendations have been reached, as there are variable results against nonenveloped viruses (Table 1.2). A few studies have reported that ethanol has a strong effect
against FCV-F9 and MNV-1. For example, Di Martino and others (2010) found that 70% ethanol
was able to inactive FCV-F9 by >4 log PFU/mL after a 10 min exposure, as evaluated by nested
RT-PCR (Di Martino et al., 2010). Malik and others (2006), using tissue culture infectious dose
50 (TCID50), showed that 70% and 90% ethanol were most effective at killing 99% of FCV-F9
after 1 min of exposure (Malik et al., 2006). Similarly, Gehrke and others (2004), using
quantitative suspension assays, suggested that 67% ethanol had a high degree of efficacy on
decontaminating FCV-F9 after 1 min contact time (Gehrke et al., 2004). Macinga and others
(2008) found that, using an infectivity assay, 70% ethanol could inactivate FCV-F9 by ≥4.75
log10 PFU/mL after a 30 s contact time (Macinga et al., 2008). Belliot and others (2008) found
that MNV-1 was significantly inactivated (>4 log PFU/mL) by 60% ethanol after 30 s exposure,
as evaluated by plaque assays and real-time RT-PCR (Belliot et al., 2008). Similarly, Magulski
and others (2009) observed ≥4 log reduction on MNV-1 with 50% ethonal after 5 min of
exposure using an infectivity assay (Magulski et al., 2009). Park and others (2010), using plaque
assays, also suggested that ≥70% ethanol was able to inactivate MNV-1 by >3.6 log with contact
times ranging from 1 min to 5 min (Park et al., 2010).
On the other hand, many studies showed that ethanol was ineffective against HNoV
surrogates. For example, D’Souza and Su (2010) using plaque assays found that treatment with
70% ethanol was not effective in reducing the infectivity of both FCV and MNV at low (~5 log
10

PFU/mL) or high (~7 log PFU/mL) titers after 30 s or 1 min contact times (D'Souza and Su,
2010). Park and others (2010) reported that 70% ethanol resulted in a 2.6 log reduction in FCV
after 5 min exposure (Park et al., 2010). The findings of Duizer and others (2004) were similar,
with FCV being inactivated <2 log after an 8 min exposure to 70% ethanol, and a 3 log-reduction
after a 30 min exposure, as evaluated by infectivity plaque assays (Duizer et al., 2004). Doultree
and others (1999) also reported that FCV was not significantly inactivated (1.25 log) at ethanol
concentrations of 75% with a contact time of 1 min (Doultree et al., 1999), which were similar to
the reports by Whitehead and McCue’s (2010), with FCV being reduced approximately 1.3 logs
after 1 min of exposure to 60-75% ethanol (Whitehead and McCue, 2010). Lages and others
(2008), using fingertips, found that ethanol concentrations of 99.5% was more effective (≥1 log
reduction) than 62% ethanol (<1 log reduciton) against FCV-F9 with contact times of 30s or 2
min, respectively (Lages et al., 2008).
Other alcohols, including 1-propanol and isopropanol, were also used to reduce FCV-F9
and MNV-1 (Table 1.2 and 1.3). For example, Gehrke and others (2004) reported that 50% to
70% of 1-propanol was effective at inactivating FCV-F9 within 30 s, using a quantitative
suspension assay. They found that 1-propanol at concentrations of 60% was the most effective,
and 50% and 70% of 1-propanol could reduce FCV-F9 by 4 log units (Gehrke et al., 2004).
Using a surface test, Magulski and others (2009) reported that MNV-1 was inactivated ≥4 logs
after a 5 min exposure to 30% 1-propanol, as evaluated by an infectivity assay (Magulski et al.,
2009).
Isopropanol was shown to be effective at inactivating FCV-F9 and MNV-1(Belliot et al.,
2008; Gehrke et al., 2004; Malik et al., 2006; Park et al., 2010), although reports by Park and
others (2010) showed almost no reduction of FCV-F9 by 50%, 70% or 90% of isopropanol after
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1 min or 5 min exposure, as determined by plaque assays (Park et al., 2010). Other studies
suggested that isopropanol has a high degree of efficacy in decontaminating FCV-F9. For
instance, Gehrke and others (2004) found that 58% of isopropanol was most effective against
FCV-F9 after 1 min of exposure, as evaluated by a quantitative suspension assay (Gehrke et al.,
2004). Similarly, Malik and others (2006) reported that using TCID50, 40% to 60% isopropanol
was most effective, which could kill 99% of FCV-F9 within 1 min (Malik et al., 2006).
Compared to FCV-F9, MNV-1 showed more resistance to isopropanol. Park and others (2010)
reported that ≥70% of isopropanol reduced the infectivity of MNV-1 by ≥2.6 log units after 5
min contact time, as evaluated by plaque assay (Park et al., 2010). Belliot and others (2008)
observed >3.8 log reduction of MNV-1 after 30 s exposure to 60% isopropanol, as determined by
infectivity assay (Belliot et al., 2008). Using surface testing, Magulski and others (2009) found
that 60% isopropanol inactivated MNV-1 by 3.02 log units after 5 min contact time using
infectivity plaque assays (Magulski et al., 2009).
Glutaraldehyde
Glutaraldehyde is an organic compound used to disinfect medical and dental equipment
and also used as a preservative in industrial cleaning agents. Glutaraldehyde has been studied as
a disinfectant agent against food-borne viruses and surrogates, including hepatitis A virus
(HAV), rotavirus, FCV-F9 and MNV-1.
Glutaraldehyde at low concentration has been shown to inactivate food-borne viruses.
Passagot and others (1987) reported that a > 3 log10 reduction was achieved after 30 min of
exposure using 0.10% glutaraldehyde and within only 3 min using 0.50% glutaraldehyde against
HAV using TCID50 assays (Passagot et al., 1987). Mbithi and others (1990) found that 2%
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glutaraldehyde reduced HAV by 99.9% after 1 min of exposure on contaminated stainless-steel
disks (Mbithi et al., 1990). Jean and others (2003) observed that disinfectant containing 5%
glutaraldehyde plus 10% quaternary ammonium was effective in inactivating HAV in solution
after a 5 min of contact time, which could reduce HAV by 7.25 logs at the final concentration of
3,000 ppm (Jean et al., 2003). Lloyd-Evans and others (1986) reported that 2% glutaraldehyde
was also effective against human rotavirus (Lloyd-Evans et al., 1986). Glutaraldehyde was also
found to effectively inactivate human norovirus surrogates, FCV-F9 and MNV-1. Using surface
tests, D’Souza and Su (2010) found that 2% glutaraldehyde effectively inactivated both FCV-F9
and MNV-1 at both low (~5 log PFU/mL) and high (~7 log PFU/mL) titers after 30 s or 1 min
exposure times (D'Souza and Su, 2010). Malik and others (2006) reported that, after a range of 1
to 10 min exposure to 2.6% glutaraldehyde, FCV-F9 was inactivated by more than 99.99%
(Malik et al., 2006). Similarly, Magulski and others (2009) observed a ≥4 log reduction of
MNV-1 treated by 2500 ppm glutaraldehyde within 5 min exposure time (Magulski et al., 2009).
Furthermore, there were no significant differences in virus reduction under either dirty or clean
conditions. Using suspension tests, Doltree and others (1999) observed complete inactivation of
FCV-F9 with 0.5% glutaraldehyde after 1 min contact time (Doultree et al., 1999).
Benzalkonium chloride:
Benzalkonium chloride (BAC) belongs to the quaternary ammonium compound (QAC)
group, which have been widely utilized in hand sanitizers (Moadab et al., 2001) and disinfectants
for hard surfaces (Gradel et al., 2004) as well as for pharmaceutical preservatives (Marple et al.,
2004) due to its effectiveness in decontaminating a broad spectrum of bacteria, viruses and fungi
in solutions (Bastiani et al., 1974; Belec et al., 2000; Jira et al., 1982). BAC at low
concentrations is reported to be non-irritating, non-toxic, and non-corrosive to food contact
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surfaces and thus can be safely used as a disinfectant in the food industry as a readily-used
antimicrobial agent. As quaternary ammonium compounds are surface acting agents, the antiviral
mechanism of BAC may have been due to the alterations in the surface components at, or
adjacent to the attachment site, which interacts with the receptor on the surface of the host cell
(Wood and Payne 1998).
BAC at 512 ppm (0.512 mg/mL) is reported to be effective against methicillin-resistant
Staphylococcus aureus (MRSA), Campylobacter, Salmonella, Escherichia coli O157:H7,
Listeria monocytogenes and Pseudomonas aeruginosa after an exposure of 5 min in both
suspension and surface tests (Riazi and Matthews, 2011). In addition to bacteria, studies have
also shown that BAC has antiviral activity against canine coronavirus (Pratelli, 2007), respiratory
syncytial virus, adenovirus, herpes simplex virus hominis type 2 and cytomegalovirus (Belec et
al., 2000). In suspension tests, in the presence of organic load, BAC effectively inactivate
enveloped viruses herpes simplex virus type 1 and human immunodeficiency virus type 1, as
well as the non-enveloped human coxsackie virus at the concentration of 0.2% w/v after 1 min
with initial viral titers of 106-107 PFU/TCID50 or syncytia-forming assay (SFU) (Wood and
Payne 1998).
Su and D’Souza (2012) reported that BAC at 0.2, 0.5, and 1 mg/mL reduced FCV-F9 and
MNV-1 at low (~5 log10 PFU/mL) titers to undetectable levels after 2 h at room temperature in
suspension tests; and high (~7 log10 PFU/mL) titers of FCV-F9 was reduced by 2.87, 3.08, and
3.25 log10 PFU/mL and high titer MNV-1 was reduced by 1.55, 2.32, and 2.75 log10 PFU/mL
with BAC at three concentrations, respectively (Su and D’Souza, 2012).
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Organic acids:
Organic acids, including lactic acid, tannic acid, and peroxyacetic acid, have been used
for inactivating human noroviruses and human enteroviruses and their surrogates. The acid
mediated mechanisms leading to a loss of infectivity have not been completely understood,
which is believed to result from the alterations of the virus capsid and nucleic acid (Cliver, 2009;
Salo and Cliver, 1976). However, whether the antiviral effect was derived from the decrease in
pH or the type of acid is still not clear. It appears that the inactivation of non-enveloped viruses
is due to the denaturation of capsid proteins due to the decrease in pH (Rodger et al., 1977)
Using suspension tests, Straube and others (2011) found that D, L-lactic acid at the
concentration of 0.3% (PH 3.4-3.5) and 0.4% (PH 3.2-3.3) could cause significant titer
reductions of FCV-F9 after 7 days of exposure at 20°C (Straube et al., 2011). Using an organic
acid-based disinfectant containing 55 to 60% formic acid and 7% glyoxylic acid, Poschetto and
others (2007) observed a ≥5 log10 reduction of FCV-F9 after 15 min contact time, estimated by
cell culture or a 2 to 3 log10 reduction after 15 min or 60 min as determined by RT-PCR
(Poschetto et al., 2007). However, the disinfectant efficacy was strongly reduced by the presence
of fetal bovine serum (FBS) or feces. Baert and others (2009) reported that 250 mg/L
peroxyacetic acid could obtain an additional 1-log reduction for MNV-1 on shredded iceberg
lettuce, and its efficacy was not influenced by the presence of organic materials (Baert et al.,
2009). Fraisse and others (2011) found that 100 ppm of peroxyacetic-based biocide effectively
inactivated FCV-F9 by 3.2 log units and MNV-1 by 2.3 log units on the lettuce leaves after 2
min of contact time, as estimated by cell culture (Fraisse et al., 2011). Whitehead and McCue
(2010) reported that one acid-based bathroom disinfectant containing 2.5% citric acid (pH 2.0)
could reduce FCV-F9 by >3.17 log10 reduction after 1 min of exposure (Whitehead and McCue,
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2010). Recently, Zhang and others (2011) found that tannic acid derived from Chinese medicinal
herbs as an inhibitor in binding to histo-blood group antigens (HBGAs) receptors, which
indicated that tannic acid may be a promising antiviral against HNoVs (Zhang et al., 2011). Su
and D’Souza (2012) reported that tannic acid at 0.2 mg/mL reduced low titers (~5 log10
PFU/mL) of FCV-F9 by 1.95 log and <1 logs of high titers (~7 log10 PFU/mL) of FCV-F9 after 2
h of contact time at room temperature. They also reported that gallic acid at 0.1, 0.2, and
0.4 mg/mL reduced low-titers of FCV-F9 by 2.50, 2.36, and 0.86 log10 PFU/mL, respectively
with little effect against high-titer FCV-F9 under the same exposure time (Su and D'Souza,
2012). Oh and others (2012) demonstrated that gallic acid in black raspberry (BRB) juice did not
show any antiviral activity against FCV-F9 or MNV-1, though BRB exhibited high efficacy
against these viruses. Acetic acid is the typical acid used with chitosan and is known to have
antibacterial activity (Oh et al., 2012). Acetic acid has been found to be effective against bacteria
such as Salmonella Typhimurium, Enterobacter sakazakii and Listeria monocytogenes (AlvarezOrdonez et al., 2009; Back et al., 2009; Vasseur et al., 1999). Davis and others (2012) found that
chitosan dissolved in 1% acetic acid reduced phiX174 by 1.19-1.29, MS2 by 1.88-5.37, FCV-F9
by 2.27-2.94, and MNV-1 by 0.09-0.28 log10 PFU/mL, respectively after incubation for 3 h at 37
°C (Davis

et al., 2012). Malic acid is a dicarboxylic acid which was first isolated from apple

juice. Malic acid at 10% combined with 1% thiamine dilauryl sulfate was found completely
inactivated E. coli O157: H7 on 10g of inoculated alfalfa seeds (Fransisca et al., 2012). Malic
acid combined with citric acid and sodium laruryl sulfate showed antiviral activity against
rhinovirus (Hayden et al., 1985). Humic acid is a principle component of humic substances,
which naturally occurs as decomposed constituents of soil. Ansorq and Rochus (1978) found that
humic acids inhibited Staphylococcus epidermidis, S. aureus, Streptococcus pyogenes, S.
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Typhimurium, P. vulgaris, E. cloacae, P. aeruginosa and C. albicans (Ansorg and Rochus,
1978). Certain modified forms of humic acid have also shown antiviral activities against herpes
simplex and human immunodeficiency viruses (Klocking et al., 2002; Schneider et al., 1996;
Van Rensburg et al., 2002).
Electrolyzed water
Electrolyzed water (aka electrolyzed oxidizing water or EOW) is produced from the
electrolysis of water containing sodium chloride. This procedure generates a solution of sodium
hypochlorite, which is the active ingredient in household bleach. EOW has been applied in the
food industry and agriculture due to its environmentally friendly nature, high efficiency, and no
adverse side effects. EOW is believed to destroy the outer cellular membrane, increase the
membrane permeability and decrease the activity of key enzymes due to its physical and
chemical properties, including low pH, high oxidation-reduction potential, high dissolved
oxygen and free chlorine (Koseki et al., 2001; Kuira and others 2002; Len et al., 2000; Liao et
al., 2007; Park et al., 2004; Zeng et al., 2010). However, there is still no definite conclusion on
the disinfection targets/and mechanisms of EOW.
The acidic form of EOW was found to effectively inactivate food-borne pathogens on the
food surfaces, including Escherichia coli, Staphylococcus aureus, Salmonella and Listeria
monocytogenes. Park and others (2006) observed 2.41 and 2.65 log CFU reductions per lettuce
leaf of E. coli O 157:H7 and L. monocytogenes respectively using acidic electrolyzed water (ACEW) (45 ppm residual chlorine) after 3 min of exposure time at 22℃ (Park et al., 2006). Koseki
and others (2003) reported 4.6 and 4.4 log CFU/g reductions of E. coli O 157:H7 and S.
Typhimurium respectively with the treatment of spot inoculated lettuce surfaces using 40 ppm
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AC-EW for 1 min (Koseki et al., 2003). Guentzel and others (2008) showed that dip treatment of
inoculated spinach and lettuce surfaces with 20 and 50 ppm AC-EW for 10 min resulted in 2.14
to 4.97 log CFU/g reductions of E. coli, S. Typhimurium, and L. monocytogenes (Guentzel et al.,
2008). Park and others (2008) reported that E. coli O 157:H7, S. Typhimurium, and L.
monocytogenes were reduced below the detection limit (0.7 log) after a 3-min treatment of ACEW (~37.5 mg/L) at room temperature on the surfaces of lettuce and spinach (Park et al., 2008).
Slightly acidic electrolyzed water (SAEW) was also reported to be effective towards
inactivating these food-borne pathogens. Issa-Zacharia and others (2010) reported that SAEW
containing 23 mg/L available chlorine effectively reduced the population of E. coli, S. aureus,
and Salmonella spp. by 5.1, 4.8, and 5.2 log CFU/mL, respectively after 60 s of treatment (IssaZacharia et al., 2010). However, the efficacy of AC-EW could be decreased by the presence of
organic matter. Park and others (2009) evaluated the effects of bovine serum on the bactericidal
activity of AC-EW on E. coli, S. Typhimurium, and L. monocytogenes inoculated surfaces of
green onions and tomatoes. They showed that AC-EW (~37.5 mg/l available chlorine
concentration) treatment alone achieved the reductions below the detection limit (0.7 log CFU/g)
after 3 min, whereas the bactericidal activity decreased with the increase of bovine serum
concentration (Park et al., 2009).
EOW was also studied for the removal of inoculated human norovirus from the surfaces
of raspberries and romaine lettuce by a simple wash. Tian and others (2011) found that an ACEW wash enhanced the binding of HNoV to raspberries and lettuce with only ~7.5% and ~4% of
HNoV removed, respectively (Tian et al., 2011).
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Ozone:
Ozone is a powerful oxidizing agent, which has been used as a disinfectant for killing
microorganisms in air and water sources. Ozone applications in the food industry typically
include decontamination of product surfaces and water treatment (Kim et al., 1999). The
mechanism of inactivation of viruses may be due to both viral RNA and capsid protein
destruction (Kim and others, 1999). Roy and others (1981) believed that damage to the viral
nucleic acid was the major cause of poliovirus 1 inactivation by ozone (Roy et al., 1981). This is
supported by the report of Shin and Sobsey (2003), which showed that virus reductions of
poliovirus 1and coliphage MS2 exposed to ozone were similar as evaluated by both RT-PCR and
infectivity assays (Shin and Sobsey, 2003). However, others suggested that ozone actually
targets the capsid protein. Kim and others (1980) found that ozone breaks the protein capsid into
subunits, which leads to the inactivation of bacteriophage f2 (Kim et al., 1980). This is evidenced
by the study of Lim and others (2010), who reported that ozone at 1 mg/liter (at pH of 7 or 5.6
and temperature of 20℃ or 5℃) effectively inactivated more than 99% of MNV-1 within 2
min, as measured by plaque assays, but RT-PCR assay significantly underestimated the
inactivation of MNV-1 (Lim et al., 2010).
Ozone has shown its efficacy on the inactivation of norovirus surrogates, including FCVF9 and MNV-1. Hirneisen and others (2011) observed >6 log TCID50/mL of FCV reduction in
water and ~2 log TCID50/mL on green onions and lettuce after 5 min of 6.25 ppm ozone
treatment. MNV-1 inoculated onto these produce items produced a >2 log reduction after 1 min
of exposure, as determined by plaque assay (Hirneisen et al., 2011). Hudson and others (2007)
reported that ozone gas, at the level of 20-25 ppm, was able to reduce the concentration of
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infectious FCV by a factor of more than 103 within less than an hour of exposure (Hudson et al.,
2007).
Hydrogen peroxide:
Hydrogen peroxide (H2O2) is also a strong oxidizer, which is often used as a bleaching or
cleaning agent. Hydrogen peroxide has shown to be effective against enteric viruses and their
surrogates. For example, Li and others (2011) found that liquid H2O2 (L-H2O2) at concentrations
of 2.1% inactivated MNV-1 and coliphage X174 on stainless steel discs by approximately 4 log10
units within 10 min, whereas for Bacillus fragilis Phage B40-8, 15% of L-H2O2 was needed to
obtain a similar reduction in 10 min, with only a <1 log10 unit reduction after 5min of exposure
to 2.52% of Vaporized H2O2 was achieved for the tested model viruses (Li et al., 2011). Tuladhar
and others (2011) reported that hydrogen peroxide vapor at 127 ppm completely inactivated
poliovirus, rotavirus, adenovirus and murine norovirus after 1 h treatment at room temperature
on carriers (Tuladhar et al., 2011). Bentley and others (2011) observed a 4 log reduction on all
tested surfaces within 20 min of exposure to 30% (w/w) H2O2 vapour. The reduction was
achieved most rapidly on vinyl flooring (10 min), while the longest was observed on stainless
steel (20 min). For glass, ceramic tile and plastic surfaces, the desired reduction titer was reached
within 15 min (Bentley et al., 2011). Malik and others (2006) found that a combination of 2%
sodium bicarbonate with 2% hydrogen peroxide killed FCV-F9 by 99.00% in 1 and 3 min, and
99.68% of the virus was killed after 10 min contact time on stainless steel coupons (Malik and
Goyal, 2006).
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Potassium monosulfate:
Potassium monosulfate (KPMS) is widely used as a powerful oxidizing agent. Currently,
KPMS is routinely used in swimming pools against Escherichia coli to keep the water clean and
safe (Anipsitakis et al., 2008). It has also been used as a mist in veterinary hospitals to
decontaminate S. aureus and S. Typhiumurium by >99.9999% with the concentration of 4% for
30 min exposure time after misting was completed (Patterson et al., 2005). In a 6-year study,
KPMS at concentrations of 1 and 10 mg/mL completely inactivated S. aureus, MRSA and
Pseudomonas aeruginosa after 10 and 2 min exposure times, respectively and no significant
variation in resistance to KPMS was observed during the period of the study (Giacometti et al.,
2005). However, only a few studies reported the application of KPMS for viral inactivation. The
KPMS-based product Virkon S was shown to completely inactivate the poultry enteric mortality
syndrome (PEMS)-associated astrovirus in an embryo model (Schultz-Cherry et al., 2001). Also,
KPMS was shown to completely inactivate FCV after 10 min of exposure (Eleraky et al., 2002).
However, this study used only FCV from animal isolates and not the HNoV surrogate strains
FCV-F9 or MNV-1.
Solomon and others (2009) reported that Virkon at 1% containing 5 mg/mL KPMS
reduced FCV-F9 from 4-5 log10 PFU/mL to undetectable levels after 10 min (Solomon et al.,
2009). Su and D’Souza (2012) reported that KPMS at 5, 10, and 20 mg/mL reduced high and
low titers of FCV-F9 and low titers of MNV-1 to undetectable levels, while high titers of MNV1 were reduced by 0.92 and 3.44 log10 PFU/mL with KMPS at 5 and 10 mg/mL, respectively
after 2 h at room temperature (Su and D’Souza, 2012).
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Trisodium phosphate
Trisodium phosphate (TSP) is considered a generally recognized as safe (GRAS)
chemical by the Food and Drug Admiminstration (FDA: Lindsay 1985), which has a pH of 12 in
a 1% solution. TSP has shown efficacy against a wide range of pathogens, including E. coli
O157: H7, Salmonella, poliovirus 1 and bacteriophages. Jerzy and others (2003) reported that
significant reductions of bacteriophage MS2 and Poliovirus 1 were obtained by using 1.0% TSP
solution on strawberries (Jerzy et al., 2003). TSP has also been evaluated as a detergent against
norovirus surrogates, including FCV-F9 and MNV-1. D’Souza and Su (2010) reported that 5%
TSP effectively inactivated high titers of MNV-1 and FCV by ≥6 log PFU/mL, and with a 5 log
reduction of low viral titers after 30s or 1 min of contact time. TSP at 2% inactivated high titers
of FCV by ≥6 log PFU/mL, but only a 1.05 log reduction for MNV-1 after 1 min exposure.,
while1% TSP reduced FCV by ~2.65 log PFU/mL, with no reduction of high titers of MNV-1
(D'Souza and Su, 2010). Su and D’Souza (2011) found that 2% and 5% TSP reduced low titers
of FCV to undetectable levels after 15 s or 30 s. Low titers of MNV-1 was reduced by ~2 - 3 log
PFU/mL by 2% TSP and to undetectable levels by 5% TSP. High titers of FCV and MNV-1
were reduced by > 5 or ~ 2- 3.4 log PFU/mL with 2% TSP, respectively, and to undetectable
levels with 5% TSP (Su and D'Souza, 2011).
Sodium metasilicate:
Sodium metasilicate is a highly soluble chemical with the pH of a 1% solution ranging
from 12.5 to 13.0. Sodium metasilicate is USDA FSIS approved as a processing aid and can be
used as an antimicrobial component of marinades for meat and poultry products up to 2% by
weight of the marinades and as a carcass rinse or spray on raw beef carcasses, subprimals, and

22

trimmings up to 6% in solution (USDA FSIS, 2011). Sodium metasilicate has been effective
against E. coli O157: H7 and Salmonella both in vitro and in beef trimmings (Carlson et al.,
2008; Geornaras et al., 2012; Pohlman et al., 2009; Weber et al., 2004), Campylobactor jejuni
and Salmonella Typhimurium in fresh chicken breast meat (Sharma et al., 2012a, b). Weber and
others (2004) found that sodium metasilicate at 0.6% (pH 12.1) resulted in complete inhibition of
E. coli O157: H7 after 5 to 10 s exposure in water at room temperature (Weber et al., 2004).
Carlson and others (2008) reported that 4% sodium metasilicate (23oC, pH 12.94) reduced E. coli
O157: H7 and Salmonella by ~1.9 and ~ 2.6 log CFU/mL, respectively from inoculated beef
hides following a 30 s- spray- 2 min- dwell- 30 s - water rinse procedure (Carlson et al., 2008).
Pohlman and others (2009) demonstrated that E. coli and Salmonella Typhimurium were reduced
by ~1 log to ≥1.5 log CFU/mL, respectively, treated with 4% sodium metasilicate from
inoculated beef trimmings (Pohlman et al., 2009). Geornaras and others (2012) compared the
efficacy of sodium metasilicate against E.coli O157:H7 and 6 non-O157 Shiga toxin-producing
E. coli (nSTEC) serogroups suggesting similar effectiveness. The initial pathogen counts were
decontaminated by 1.3 to 1.5 log CFU/cm2 from inoculated beef trimmings after immersion for
30 s in solution of 4% sodium metasilicate (pH 12.5) (Geornaras et al., 2012). Adler and others
(2011) observed that brine solution containing 2.2% sodium metasilicate immediately reduced
E.coli O157:H7 by ≥2.4 log CFU/mL (0 h) (Adler et al., 2011).
Sodium metasilicate has also been evaluated for efficacy against viral pathogens,
including human rotaviruses and vesicular stomatitis viruses (Springthorpe et al., 1986; Wright,
1970). Springthorpe and others (1986) tested the efficacy of 69 commercial and 7 noncommercial disinfectant formulations against human rotaviruses and found that the efficacy of
quaternary ammonium-based disinfectant formulations was greatly improved by adding 0.5 to
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5% sodium metasilicate. They believed that quaternary ammonium compounds and sodium
metasilicate may act in an additive or synergistic manner to inactivate human rotaviruses
(Springthorpe et al., 1986). However, Wright (1970) demonstrated that sodium metasilicate at
5% (pH 12.1) was not viricidal against vesicular stomatitis virus after 10 min contact time
(Wright, 1970).
Natural antimicrobial extracts:
As the global consumer’s demand for natural ingredients to reduce pathogenic
microorganism from foods is steadily increasing, the investigation of the effectiveness of
potential natural antimicrobials is necessary. Some natural extracts such as Cranberry juice and
cranberry proanthocyanidins, Black raspberry juice, Grape seed extract, Pomegranate juice and
pomegranate polyphenols, Hibiscus sabdariffa have shown antibacterial and antiviral activities.
Cranberry extracts have been reported to have antibacterial activity against E. coli O157:
H7, Salmonella Typhimurium, Listeria Monocytogenes, Helicobacter pylori and Staphylococcus
aureus (Matsushima et al., 2008; Nogueira et al., 2003; Wu et al., 2008). In addition to
antibacterial property, they have also shown antiviral activity against reovirus, bacteriophages
T4, phiX-174 and MS2, rotavirus, influenza virus and human norovirus surrogates (Lipson et al.,
2007; Su et al., 2010a; Su et al., 2010b; Weiss et al., 2005). The mechanism of cranberry extracts
on the antimicrobial activity has not been well established. Wu and others (2008) believed that
both low pH and phenolics may cause the antibacterial effect by observing cell wall and cell
membrane damage treated with cranberry concentrate, which may make bacteria vulnerable to
cranberry concentrate (Wu et al., 2008). Similarly, cranberry extracts may injure the viral capsid
structure or viral nucleic acid to interfere with viral replication. Su and others (2010a) reported
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that FCV-F9 at ~ 5 log10 PFU/mL was reduced to undetectable levels after 1h of exposure to
cranberry juice (CJ) (pH 2.6) or 0.15, 0.30, and 0.60 mg/mL cranberry proanthocyanidins (PAC)
at room temperature. MNV-1 was reduced by 2.06 log10 PFU/mL with CJ, and 2.63, 2.75, and
2.95 log10 PFU/mL with the three tested PAC solutions, respectively (Su et al., 2010a). In
another time- dependent study by these investigators, FCV-F9 at low viral titers was reduced by
~5 log10 PFU/mL within 30 min treated by CJ (pH 2.6 and pH 7.0) and the two PAC solutions
(0.15, 0.30 mg/mL). MNV-1 titers were decreased similarly with CJ at pH 2.6 or 7.0. In most
cases, viral reduction within the first 10 min of treatment accounted for 50% of the total
reduction (Su et al., 2010b).
Pomegranate juice and pomegranate polyphenols exhibited a wide range of antioxidant,
anticancer, anti-inflammatory and antimicrobial properties (Braga et al., 2005; Haidari et al.,
2009; Kotwal, 2008; Lee et al., 2010; Neurath et al., 2005; Prashanth et al., 2001; Reddy et al.,
2007). Pomegranate extracts have shown antibacterial activities against Salmonella
Typhimurium, Staphylococcus aureus, E. coli, and Bacillus subtilis (Braga et al., 2005;
Prashanth et al., 2001). They are also reported to have antiviral properties against influenza virus,
HIV-1, poliovirus, herpes virus, poxvirus, and human norovirus surrogates (Haidari et al., 2009;
Jayaprakasha et al., 2006; Konowalchuk and Speirs, 1976; Kotwal, 2008; Neurath et al., 2005;
Su et al., 2010c, 2011). These antiviral effects were attributed to the high content of polyphenols,
which were believed to act directly on the viral particles to block the attachment of the viruses to
the cell receptors (Haslam, 1974). Pomegranate juice and pomegranate polyphenols were shown
to cause 2.56, 1.32, and 0.32 log reduction for low titers of FCV-F9, MNV-1, and MS2,
respectively, after treatment by pomegranate juice for 1 h at room temperature. The effects were
decreased using high titers of three tested viruses. Pomegranate polyphenols at 8, 16, 32 mg/mL
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were shown to reduce both low and high titers of FCV-F9 to undetectable levels within 1 h.
MNV-1 at low titers was reported to be reduced by 1.30, 2.31, and 3.61 log10 PFU/ mL and at
high titers by 1.56, 1.48, and 1.54 log10 PFU/mL with three tested concentrations of PP,
respectively, after 1 h by these investigators (Su et al., 2010c). According to the time-dependent
study carried out by Su and others (2011), PJ and PP were found as rather rapid acting, resulting
in  50% reduction within the first 20 min of treatment for all tested viruses. FCV-F9 and MNV1 at titers of ~ 5 log10 PFU/mL were reduced by 3.12 and 0.79 log10 PFU/mL, respectively, using
PJ within the first 20 min. Titer reductions of 4.02 and 0.68 log10 PFU/mL with 2 mg/mL PP and
5.09 and 1.14 log10 PFU/mL with 4 mg/mL PP were reported by these investigators for FCV-F9
and MNV-1, respectively, after 20 min (Su et al., 2011).
Hibiscus sabdariffa are prepared as hot and cold beverages worldwide, and is classified
as a GRAS ingredient for the food industry (CDC 2006). In addition, aqueous extracts of
Hibiscus sabdariffa have been used in folk medicine in the treatment of hypertension (Odigie et
al., 2003; Olaleye, 2007; Wang et al., 2000). Hibiscus anthocyanins, a group of phenolic natural
pigments present in calyces, have been found to have cardioprotective, hypocholesterolemic,
antioxidative and heaptoprotective effects in animals (Chen et al., 2003; Jonadet et al., 1990;
Wang et al., 2000). Moreover, the aqueous extracts were reported the presence of hibiscitrin,
gossypitrin, sabdaritrin, flavonol glycosides and some organic acids including citric, malic,
tartaric and ascorbic (Ali et al., 2005; Cowan, 1999; Tsai et al., 2002). Aqueous extracts of H.
sabdariffa have exhibited a wide range of antimicrobial properties against Pasteurella,
Pseudomonas, Proteus, Streptococcus, P. aeruginosa, Lactobacillus sp., Bacillus sp.,
Corynebacterium sp., Salmonella, Escherichia coli O157:H7 And Listeria monocytogenes (Oboh
and Elusiyan, 2004; Pliego, 2007; Sharaf et al., 1966). The mode of action includes phenols that
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inhibit metabolic enzymes of the cells leading to their inability to reproduce. The phenolic
compound, anthocyanins, extracted from Hibiscus sabdariffa were suggested to complex with
nucleophilic amino acids of the cell wall, resulting the loss of function (Cowan, 1999; Tsai et al.,
2002). However, phenols may not be the only compound responsible for all the antimicrobial
activities of Hibiscus sabdariffa. Roman (2006) found that rifamycine, a precursor of the
antibiotic rifampicin, was present in Hibiscus sabdariffa extracts (Roman 2006).
Based on the current literature, the aims of this research were to (1) investigate the
antiviral activity of benzalkonium chloride at 0.32 mg/mL and KPMS against human norovirus
surrogates over 1 h at room temperature using suspension and carrier tests and (2) determine the
ability of sodium metasilicate to inactivate human norovirus surrogates at RT over 1 h for
application in the food industry and prevent human noroviral transmission.
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Table 1.1： Examples of studies using chlorine against FCV-F9 and MNV-1

Viruses

Concentration

Contact time

Initial titer

Reduction in log10
PFU/mL

Method

Reference

FCV-F9

15ppm (lettuce)

2 min

107 TCID50/mL

2.9

Fraisse et al. 2011

3,000ppm (suspension)

10 min

>5 log units

200 mg/L= 200 ppm
(lettuce and pepper)
5,000ppm (surface)

15 s or 30 s
30 s or 1 min

300 ng/mL= 0.3ppm (suspension)
100ppm, 1000ppm (surface)

5 min
1 min

2 x 105~ 1 x 106
TCID50/mL
~5 log10 PFU/mL
~7 log10 PFU/mL
~5 log10 PFU/mL
~7 log10 PFU/mL
2.6 x 106 TCID
NR

Plaque assay and
qRT-PCR
RT-PCR and
qRT-PCR
Plaque assay

100, 1000 ppm (surface)

10 min

NR

3.2, 6.6

Plaque assay

200, 400, 800, 5000ppm (stainless
steel, lettuce and strawberry)

1-10 min

NR

Plaque assay

100, 250, 500, 1000 and 5000 ppm
(suspension)
4500-5000 ppm (suspension)
5500 ppm

1 min

NR

TCID50

Doultree et al., 1999

15 min
15 min

NR
NR

<800 ppm <1 (ss)
5000 ppm 3.4 (ss)
800 ppm 1.5 (ls)
<500 ppm <3
5000 ppm 5
Without feces: >5
With feces: 3

Su and D’Souza,
2011
D’Souza and Su
2010
Urakami et al. 2007
Whitehead and
McCue, 2010
Jimenez and Chiang,
2006
Gulati et al., 2001

Plaque assay and
RT-PCR

Poschetto et al., 2007

1.9 min

NR

3

Plaque assay

Park and Sobsey,
2011

5000 ppm (fecally soiled stainless
steel surface)

NR= Not Reported
qRT-PCR= Quantitative reverse transcription- polymerase chain reaction
TCID50= Tissue culture infectious dose 50%
ss = stainless steel; ls = lettuce and strawberry
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To undetectable levels
≤1.4
~5
>6
>4.6 log units
<2.27, >4.2

Plaque assay
TCID50
Plaque assay

Duizer et al. 2004

Table 1.1：Examples of studies using chlorine against FCV-F9 and MNV-1 (Continued)
Viruses

Concentration

Contact time

Initial titer

Reduction in log10
PFU/mL

Method

Reference

MNV-1

15ppm (lettuce)

2 min

3 x 106 TCID50/mL

1.4

Fraisse et al. 2011

0.1 mg/L
0.5 mg/L
0.26%= 2600 ppm
(suspension)
200mg/L (lettuce and
pepper)
3000ppm (surface)

120 min
0.5 min
0.5 min

NR
NR
NR

>4
>4
>4

15 s or 30 s
5 min or 10 min

~5 log10 PFU/mL
~7 log10 PFU/mL
NR

3.2 min

NR

2~3
<1.3
Complete inactivation
4
3

Plaque assay and qRTPCR
Plaque assay and realtime RT-PCR
Plaque assay and realtime RT-PCR
Plaque assay

5000ppm (fecally soiled
stainless steel surface)

NR= Not Reported
qRT-PCR= Quantitative reverse transcription- polymerase chain reaction
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Plaque assay and realtime RT-PCR
Plaque assay

Kitajima et al. 2010
Belliot et al. 2008
Su and D’Souza
2011
Girard et al., 2010
Park and Sobsey,
2011

Table 1.2: Examples of studies using ethanol, 1-propanol and 2-propanol against FCV-F9 and MNV-1

Viruses

Chemical

Concentration

Contact time

Initial titer

Reduction in log10
PFU/mL

Method

Reference

FCV-F9

Ethanol

70%
70%

10min
30min

>4
3

nested RT-PCR
RT-PCR and qRT-PCR

Martino et al. 2010
Duizer et al. 2004

70%

30s or 1min

Not effective

Plaque assay

70% and 90%

1min

4.5 log10 PFU/mL
2 x 105~ 1 x 106
TCID50/mL
~5 log10 PFU/mL
~7 log10 PFU/mL
107 TCID50/mL

TCID50

67%

1min

NR

Most effective, killing
99% of FCV
Most effective

Plaque assay

Gehrke et al. 2004

70%
75%
60% (surface)

30s
1min
1min

NR
~5 log10 PFU/mL
NR

≥4.75
1.25
1.3

Plaque assay
TCID50
Plaque assay

50% or 70%
99.5%, 62% (fingertips)

5min
30s or 2min

NR
NR

≥2.2
≥1, <1

70%

30s or 1min

0

70%, 90%
60%

5min
30s, 1min or
3min
5 min

~5 log10 PFU/mL
~7 log10 PFU/mL
NR
NR

Plaque assay
Fingerpad and Plaque
assay
Plaque assay

Macinga et al. 2008
Doultree et al. 1999
Whitehead and
McCue 2010
Park et al., 2010
Lages et al. 2008

≥3.6
>4

NR

≥4

MNV-1

50% (surface)

NR= Not Reported
qRT-PCR= Quantitative reverse transcription- polymerase chain reaction
TCID50= Tissue culture infectious dose 50%
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Plaque assay
Plaque assay and RTqPCR
Plaque assay

D’Souza and Su,
2010
Malik et al. 2006

D’Souza and Su.
2010
Park et al., 2010
Belliot et al. 2008
Magulski et al. 2009

Table 1.2: Examples of studies using ethanol, 1-propanol and 2-propanol against FCV-F9 and MNV-1 (Continued)
Viruses

Chemical

Concentration

Contact time

Initial titer

Reduction in
log10 PFU/mL

Method

Reference

FCV-F9

1-propanol

50% and 70%
60% (suspension)
30% (surface)

30s
30s
5 min

NR

Plaque assay

Gehrke et al. 2004

NR

4
Most effective
≥4

Plaque assay

40% to 60%

1 min

107 TCID50/mL

TCID50

50%, 70% or 90%
58% (suspension)

1 min or 5 min
1 min

NR
NR

Plaque assay
Plaque assay

Park et al., 2010
Gehrke et al. 2004

≥70%
60%

5 min
30 s, 1 min or 3
min
5 min

NR
NR

most effective,
killing 99%
almost no
reduction
Most effective
>2.6
3.86 (30 s), >4

Magulski et al.
2009
Malik et al. 2006

Park et al., 2010
Belliot et al. 2008

NR

3.02

Plaque assay
Plaque assay and
qRT-PCR
Plaque assay

MNV-1
FCV-F9

MNV-1

2-propanol

60% (surface)

NR= Not Reported
qRT-PCR= Quantitative reverse transcription- polymerase chain reaction
TCID50= Tissue culture infectious dose 50%
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Magulski et al.
2009

Table 1.3: Examples of studies using glutaraldehyde against FCV-F9 and MNV-1

Viruses

Concentration

Contact time

Initial titer

Reduction in log10
PFU/mL

Method

Reference

FCV-F9

2% (surface)

30 s or 1 min

MNV-1

1 min
1-10 min
30 s or 1 min

2500ppm (stainless steel)

5 min

≥4
≥6
~5
>99.99%
≥4
≥6
≥4

Plaque assay

0.5% (suspension)
2.6% (fabrics and carpets)
2% (surface)

~5 log10 PFU/mL
~7 log10 PFU/mL
~5 log10 PFU/mL
NR
~5 log10 PFU/mL
~7 log10 PFU/mL
NR

D’Souza and Su
2010
Doultree et al. 1999
Malik et al., 2006
D’Souza and Su
2010
Magulski et al., 2009

NR= Not Reported
qRT-PCR= Quantitative reverse transcription- polymerase chain reaction
TCID50= Tissue culture infectious dose 50%
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Plaque assay
TCID50
Plaque assay
Plaque assay

Table 1.4: Examples of studies using organic acids against FCV-F9 and MNV-1

Viruses

Chemical

Concentration

Contact time

Initial titer

Reduction in log10
PFU/mL

Method

Reference

FCV-F9

Formic acid and
glyoxylic acid
Peroxyacetic acid
(lettuce leaves)
Citric acid

55~60% (FA) + 7% (GA)

NR

≥5
2 to 3 log units
3.2

Plaque assay
RT-PCR
Plaque assay

Poschetto et al., 2007

100 ppm

15 min
15 min or 60 min
2 min

2.5%

1 min

NR

Plaque assay

Tannic acid

0.2 mg/mL

2h

Gallic acid

0.1, 0.2, and 0.4 mg/mL

Peroxyacetic acid
(lettuce leaves)

100 ppm

~5log10PFU/mL
~7log10PFU/mL
~5log10PFU/mL
~7log10PFU/mL
NR

Whitehead and
McCue, 2010
Su and D’Souza,
2012

MNV-1

2 min

NR

NR= Not Reported
qRT-PCR= Quantitative reverse transcription- polymerase chain reaction
RT-PCR= Reverse transcription- polymerase chain reaction
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>3.17
1.95
<1
2.50, 2.36 and 0.86
Little effect
2.3

Plaque assay

Plaque assay

Fraisse et al., 2011

Fraisse et al., 2011

Table 1.5: Examples of studies using ozone and hydrogen peroxide against FCV-F9 and MNV-1

Viruses

Chemical

Concentration

Contact time

Initial titer

FCV-F9

Ozone

6.25 ppm (water)
6.25 ppm (produce)
20- 25 ppm

5 min

NR

<1h

NR

1 mg/liter
6.25 ppm (produce)

2 min
1 min

NR
NR

>99%
>2 log TCID50/mL

V- H2O2 30% (w/w)
(carriers)
L-H2O2 2.1% (stainless
steel)
V- H2O2 2.52% V- H2O2 127
ppm (carriers)

20 min

NR

4

10 min
5 min
1h

NR

~4
<1
To undetectable levels

MNV-1

FCV-F9
MNV-1

Hydrogen
peroxide

NR

NR= Not Reported
qRT-PCR= Quantitative reverse transcription- polymerase chain reaction
TCID50= Tissue culture infectious dose 50%
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Reduction in log10
PFU/mL
>6 log TCID50/mL
~2 log TCID50/mL
>3

Method

Reference

TCID50

Hirneisen et al.
2011
Hudson et al.
2007
Lim et al. 2010
Hirneisen et al.
2011
Bentley et al. 2011

qRT-PCR and
plaque assay
TCID50
TCID50
Plaque assay
Plaque assay
Plaque assay
Plaque assay

Li et al. 2010
Tuladhar et al.
2012

Table 1.6: Examples of studies using trisodium phosphate against FCV-F9 and MNV-1

Viruses

Concentration

Contact time

Initial titer

FCV-F9

1%
2%
5%
1%
2%
5%
2%
5%
2%
5%
1%
2%
5%
1%
2%
5%
2%
5%
2%
5%

30 s or 1 min
1 min

~ 7 log10 PFU/mL

MNV-1

~ 5 log10 PFU/mL

15 s or 30 s

~ 7 log10 PFU/mL
~ 5 log10 PFU/mL

30s or 1 min
1 min

~7 log10 PFU/mL

~ 5 log10 PFU/mL

15 s or 30 s

~ 7 log10 PFU/mL
~ 5 log10 PFU/mL

NR= Not Reported
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Reduction in log10
PFU/mL
~ 2.65
≥6
≥6
~5
~5
~5
>5
To undetectable levels
To undetectable levels
To undetectable levels
0
1.05
≥6
1.69
~5
~5
~ 2 – 3.4
To undetectable levels
~2-3
To undetectable levels

Method

Reference

Plaque assay

D’Souza and Su, 2010

Plaque assay

D’Souza and Su, 2010

Plaque assay

Su and D’Souza, 2011

Table 1.7: Advantages, disadvantages and applications of disinfectants reviewed in this chapter
Chemicals

Advantages

Disadvantages

Applications

References

Bleach food;
carcinogenic
Low cost; easily

byproducts;

available; broad

inactivated by

spectrum against

organic matter

Household cleaning products;
Chlorine

Allwood et
public sanitation, disinfection

bacteria, viruses,

rapidly; caustic to

al., 2004
and antisepsis

fungi, algae and

tissues and

mycoplasmas

equipment; skin
irritation; potential
safety problems
Long contact time

Effective against

required; not

gram-positive and

effective against

Skin antiseptic; alcohol-based

D’Souza and

gram-negative

some viruses and

hand sanitizers

Su, 2010

bacteria

bacterial spores;

Alcohols

evaporate quickly
Non corrosive to
metal; effective
Toxic to human and
against bacteria,
animals; long

Disinfecting medical and dental

contact time; must

equipment; industrial water

be used in a well

treatment; preservertive

viruses, fungi,
Glutaraldehyde

Doltree et al.,

spores and parasites;

1999

remains effective in
ventilated area
the presence of
organic matter
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Table 1.7: Advantages, disadvantages and applications of disinfectants reviewed in this chapter
(Continued)
Chemicals

Advantages

Disadvantages

Applications

References

Non-alcohol-based hand
Non-irritating to
Slow- acting; not

sanitizers; hard surface

effective against

disinfectants; surgical

Moadab et

gram-negative

instrument sterilizing solutions;

al., 2001

bacteria or spores

clinical settings disinfectants;

skin; not corrosive;
Benzalkonium
has been used for
chloride
decades in hospital
environment
pharmaceutical preservatives
Less reaction with
Disinfecting surfaces; red meat
organics; wider pH

Not effective against

Organic acids

Fraisse et al.,
carcass spray; fruits and

range; no toxic

spores

2011
vegetables

residues
Kill spores and many
viruses and bacteria;
On-site production

Lose potency fairly

of disinfectant; can

quickly; equipment

be applied directly

costly

Electrolyzed
water

Disinfectant on food contact

Koseki et al.,

surfaces, fruits and vegetables

2001

on fresh food
products
Inactivation by

Sanitizers; process water;

organic matter; 10

products (fruits, vegetables and

Kim et al.,

ppm can be harmful

juices); gas (control mold in

1999

to human health

storage)

Broad spectrum
Ozone

against bacteria,
viruses and fungi
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Table 1.7: Advantages, disadvantages and applications of disinfectants reviewed in this chapter
(Continued)
Chemicals

Advantages

Disadvantages

Applications

References

not effective against
viruses, bacterial
spores, fungal
spores,
A valuable

Cryptosporidia,

bleaching, cleansing

Giardia,

and deodorizing

mycobacteria;

Hydrogen

Skin antiseptic; disinfectant;

peroxide

Li et al., 2011
chemical sterilant

agent; no toxic

damaging to tissues;

residues

moderately
corrosive;
ineffective in the
presence of organic
matter

Potassium
Anipsitakis et
peroxymonosulf

Fast- acting

Corrosive

Pool and spa disinfectants
al., 2008

ate
Approved by FDA

Relatively high cost

Cleaning agent; approved for

to be a GRAS

compared to

treatment of beef carcasses

chemical;

chlorine

Trisodium
Lindsay 1985

phosphate
Processing aid as an antimicrobial
Approved by USDA
Sodium
metasilicate

Relatively high cost

in marinades for meat products; a

compared to

carcass rinse or spray on beef

chlorine

carcasses, subprimals, and

FSIS to be used in

USDA FSIS,

food; no adverse

2011

effect in food
trimmings
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Panel A

Panel B

Panel C

Figure 1.1: Chemical structures of disinfectants evaluated in this work. Panel A- benzalkonium
chloride; Panel B- potassium peroxymonosulfate; Panel C- Sodium metasilicate
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Abstract
Human noroviruses, the major cause of acute nonbacterial gastroenteritis worldwide, are
easily transmitted via person-to-person and contaminated food-contact surfaces. This research
determined inactivation of human norovirus surrogates, feline calicivirus (FCV-F9) and murine
norovirus (MNV-1), by benzalkonium chloride (BAC) and potassium peroxymonosulfate
(KPMS) over 1 h at room temperature using suspension and carrier (stainless-steel coupons)
tests. Virus recovery after triplicate treatments was evaluated using infectious plaque assays and
compared to controls. In suspension tests, 0.32 mg/mL BAC caused 1.94 and 2.59 log PFU/mL
reductions of FCV-F9 at low and high titers after 1 h, respectively; and > 3 and 1.47 log
reduction of MNV-1 at low and high titers, respectively. KPMS at 5 and 10 mg/mL reduced both
viruses at low titers within 30 s and high titers of FCV-F9 to undetectable levels after 2 min and
30 s, respectively. KPMS at 5 mg/mL had little effect against high titers of MNV-1, though 10
mg/mL KPMS caused a 4.61 log reduction after 5 min. Using carrier tests, KPMS at 5 and 10
mg/mL reduced both viruses at low titers after 30 s. High titers of FCV-F9 and MNV-1 required
10 mg/mL KPMS for 10 and 15 min, respectively for complete inactivation. Carrier tests with
0.32 mg/mL BAC reduced low titers of both viruses to undetectable levels after 1 h without
significant reduction of high titers even after 2 h; simulated dirty conditions showed decreased
viral reduction. These results indicate that KPMS causes viral reduction within short contact
times, while BAC requires longer contact.
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Introduction
Human noroviruses (HNoVs) are considered as the most common cause of acute nonbacterial gastroenteritis in the world, that are currently responsible for approximately 90% of
non-bacterial enteric outbreaks (Scallan et al., 2011; Siebenga et al., 2009; Lindesmith et al.,
2003). These viruses can be transmitted via contaminated water, food, surfaces, or through direct
contact with infected persons (Goodgame et al., 2006). HNoVs are quite persistent in the
environment being detected on food-contact surfaces for up to 7 days at room temperature
(D'Souza et al., 2006; Liu et al., 2009). They can persist in water and foods, such as marinated
mussels, lettuce, green onions, strawberries and ready-to-eat products for several days (Bidawid
et al., 2004; Green et al., 1998, 1999; Hewitt and Greening, 2004). Although, HNoV infection
itself is self-limiting in healthy individuals, they can be life-threatening to the elderly and
immunocompromised (Siebenga et al., 2009; Donaldson et al., 2010). HNoV outbreaks result in
economic losses from product recalls or public health costs, as well as loss of labor due to
inability of employees to report to work. Outbreaks related to cruise-ships, nursing homes, and
elderly care facilities continue to be reported annually (Cheesbrough et al., 2000; Anderson et al.,
2001; Center for Disease Control and Prevention, 2002; Scallan et al., 2011).
Since HNoVs cannot be cultivated in the lab, cultivable surrogates including feline
calicivirus, FCV-F9 and murine norovirus, MNV-1, are used to determine efficacy of
inactivation using infectivity plaque assays. Currently, chemical disinfectants that are utilized for
HNoV decontamination include chlorine, sodium hypochlorite (household bleach),
glutaraldehyde, and other quaternary ammonium compounds (Jimenez and Chiang, 2006; Jean et
al., 2003; Solomon et al., 1998). These chemicals are reported to be effective on contact surfaces
against FCV-F9 and MNV-1 (Park and Sobsey, 2011; Duizer et al., 2004; D’Souza and Su,
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2010). However, some of the disadvantages of these chemicals include their corrosive nature that
can cause damage to equipment including rust and staining of surfaces and are harmful during
handling. Also, carcinogenic byproducts can be formed by the interaction of chlorine with
organic matter (Dunnick and Melnick, 1993). Therefore, it is important to explore alternative
chemical disinfectants to effectively inactivate HNoVs that have a broad range of antimicrobial
activity against nosocomial infections.
Benzalkonium chloride (BAC) is a chemical that has been used in hospital environments
for surface disinfection and decontamination against a wide range of pathogenic bacteria. BAC at
512 ppm (0.512 mg/mL) is reported to be effective against methicillin-resistant Staphylococcus
aureus (MRSA), Campylobacter, Salmonella, Escherichia coli O157:H7, Listeria
monocytogenes and Pseudomonas aeruginosa after an exposure time of 5 min in both suspension
and surface tests (Riazi and Matthews, 2011). In addition to bacteria, studies have also shown
that BAC has antiviral activity against canine coronavirus (Pratelli, 2007), respiratory syncytial
virus, adenovirus, herpes simplex virus hominis type 2 and cytomegalovirus (Belec et al., 2000).
Potassium peroxymonosulfate (KPMS) is another chemical that is routinely used in swimming
pools to keep the water clean, and is effective against Escherichia coli after 1 h at a dose of 25
ppm (0.025 mg/mL) (Anipsitakis et al., 2008). Previous studies have also shown its effectiveness
against veterinary isolates of FCV and the poultry enteritis mortality syndrome-associated
astrovirus (Eleraky et al., 2002; Schultz-Cherry et al., 2001). Therefore, routinely used chemical
disinfectants for bacterial disinfection in these facilities may also have the potential to inactivate
HNoVs and/or HNoV surrogates to prevent their spread.
With the alarming increase in HNoV outbreaks and their emerging virulent forms such as
GII.4 that are known to cause death in the elderly and immune-compromised (Siebenga et al.,
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2010), it has become imperative to implement improved control strategies in high risk areas
including hospitals, elderly-care facilities, cruise-ships, and the food environment.
Previously, using suspension tests, it was shown that BAC (0.2, 0.5, and 1 mg/mL) and
KPMS (5, 10, and 20 mg/mL) can reduce the titers of FCV-F9, MNV-1, and bacteriophage MS2
after 2 h at room temperature (Su et al., 2012). In this study, the time-dependence effects of
benzalkonium chloride (BAC at 0.32 mg/mL) and potassium peroxymonosulfate (KPMS at 5
and 10 mg/mL) against FCV-F9 and MNV-1 over 1 h at room temperature were compared in
vitro using suspension tests and carrier tests on stainless-steel coupons under clean and simulated
dirty conditions. The infectivity after treatment was evaluated by using infectious plaque assays
and compared to control (water-treated) viruses.

Materials and Methods
Virus Stocks
Feline calicivirus (FCV-F9) and its host, Crandell Reese Feline Kidney (CRFK) cells,
were obtained from American type culture collection (ATCC) (Manassas, VA). Murine
norovirus (MNV-1) was kindly provided by Dr. Skip Virgin (Washington University, St. Louis,
MO), and its host, RAW 264.7 cells were obtained from the University of Tennessee cell culture
collection. Viral stocks were obtained as previously described using their respectively confluent
cell lines in 175cm2 flasks (D’Souza et al., 2011; Su et al., 2011). Viral titer was quantified using
infectious plaque assays as described below.
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Chemicals and Treatments
Benzalkonium chloride (BAC), obtained from MP Biomedicals (Illkirch, France), was
diluted with sterile de-ionized water to reach a concentration of 0.32 mg/mL and then filtersterilized with a 0.2 μm filter (Fisher Scientific, GA, USA). Potassium peroxymonosulfate
(KPMS) (Tokyo Chemical Industry Co., Japan) was prepared in sterile de-ionized water to reach
final concentrations of 5 and 10 mg/mL and filter-sterilized with a 0.2 μm filter (Fisher
Scientific, GA, USA).
For the suspension test, one volume (167 µl) of BAC and KPMS were mixed with an
equal volume of FCV-F9 or MNV-1 at high and low titers of ~7 log10 PFU/mL and ~5 log10
PFU/mL to obtain a final concentration of 0.16 mg/mL BAC or 2.5 mg/mL and 5 mg/mL KPMS,
respectively, and incubated for specific time intervals of 0, 5, 10, 15, 30 and 60 min at room
temperature (22oC). For the carrier test, stainless steel coupons sterilized by autoclaving were
used as a surface model (fomite). Under clean conditions, MNV-1 and FCV-F9 were inoculated
on sterile coupons at high and low titers of ~7 log10 PFU/mL and ~5 log10 PFU/mL and allowed
to dry for 1 h at room temperature in a BioSafety Level 2 hood. After drying, the coupons were
treated with BAC or KPMS and sampled at specific time intervals of 0, 5, 10, 15, 30 and 60 min
at room temperature (RT). Heat-inactivated fetal bovine serum (5% FBS, HyClone Laboratories,
Inc, Logan, Utah) was added into the virus stocks to simulate an organic load to test the efficacy
of chemicals against HNoV surrogates in the presence of dirty conditions using the same
procedures as described above for clean conditions.
Sterile water was used as non-treated controls to test the viral recovery and to compare
with treated samples. All the chemical treatments were neutralized after their appropriate
treatment contact times by serially diluting the virus-chemical mix in Dulbecco’s Modified
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Eagle’s Medium/Ham’s F-12 (HyClone Laboratories, Inc, Logan, Utah) containing 10% heatinactivated FBS followed by serial dilutions in DMEM-F12 containing 2% FBS and plaque
assayed as described below.

Plaque Assays for FCV-F9 and MNV-1
Serial dilutions (0.5 mL) of control and treated viruses were inoculated onto the confluent
CRFK cells for FCV-F9 and RAW 264.7 cells for MNV-1 in 6-well plates, and incubated for 2.5
h at 37℃ in a CO2 incubator. Plaque assays were performed as previously described (D’Souza et
al., 2006; D’Souza et al., 2009; Su et al., 2011). Briefly, overlay medium containing 0.75% noble
agar (Sigma-Aldrich, St. Louis, MO) was added to each infected or control well and incubated
for 2~3 d at 37oC under 5% CO2. Finally, overlay media containing neutral red (Sigma-Aldrich,
St. Louis, MO) was added for visualization of plaques after incubation.

Statistical Analysis
All treatment and controls were replicated thrice in duplicate. A one-way analysis of
variance (ANOVA) was used to test for differences in means of plaque counts among treatments
and means were analyzed using a completely randomized design at p<0.05 in SAS program
(version 9.3, SAS Institute, Cary, NC, USA). If statistically significant differences were found
using the ANOVA, the Tukey’s Post Hoc test was used to analyze differences in means between
treatments.
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Results
Reduction of FCV-F9 and MNV-1 by 0.32 mg/mL BAC in suspension tests
BAC at 0.32 mg/mL concentration for 5, 10 and 15 min contact time caused <1 log10
PFU/mL reduction for FCV-F9 and MNV-1 at low titers, with ~1 log10 PFU/mL of reduction
after 30 min, and with greater reduction of 1.94 log10 PFU/mL or ≥3 log10 PFU/mL for FCV-F9
and MNV-1, respectively, after 1 h at RT. Using high viral titers, FCV-F9 and MNV-1 were
reduced by ~1 log10 PFU/mL after 10 min of exposure time. FCV-F9 titer was reduced by 2.59
log10 PFU/mL after 1 h, while a 1.47 log reduction was observed for MNV-1 at RT (Table 2.1).

Reduction of FCV-F9 and MNV-1 by 5 and 10 mg/mL KPMS in suspension tests
FCV-F9 and MNV-1 were undetectable after exposure to 5 or 10 mg/mL of KPMS after
10 min (data not shown). Therefore shorter contact times for 0, 30 s, 1 min, 2 min and 5 min
were further evaluated at the same concentrations of KPMS. Low titers of FCV-F9 and MNV-1
were undetectable within 30 s. However, KPMS at 5 mg/mL reduced high titers of FCV-F9 by
≥5 log10 PFU/mL after 2 min, but caused little reduction (~0.5 log) of high titers of MNV-1 after
5 min of exposure time. Increasing the concentration of KPMS to 10 mg/mL for 30 s of contact
time resulted in ≥5 log10 PFU/mL reduction for high titers of FCV-F9 and also had a significant
effect on high titers of MNV-1 resulting in a 4.61 log reduction after 5 min at RT (Table 2.2).

Reduction of FCV-F9 and MNV-1 by 0.32 mg/mL BAC in clean coupon tests
Since little reduction was achieved in the suspension test after 1 h of exposure and it is
generally recognized that chemical efficacy is higher in suspension than carrier tests, longer
contact times for BAC at a concentration of 0.32 mg/mL on stainless steel coupons were needed
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for testing. Low titers of FCV-F9 and MNV-1 were reduced to undetectable levels after 1 or 2 h
of exposure at RT. High titers of FCV-F9 were reduced by 1.45 and 1.05 log10 PFU/mL with the
treatment of BAC after 1 h and 2 h, respectively. However, lower reductions of ~0.7 log10
PFU/mL for high titers of MNV-1 were achieved after 1 or 2 h of exposure to 0.32 mg/mL of
BAC at RT (Table 2.4).

Reduction of FCV-F9 and MNV-1 by 5 and 10 mg/mL KPMS in clean coupon tests
KPMS at 5 and 10 mg/mL concentrations reduced FCV-F9 and MNV-1 at low titers to
undetectable levels within 30 s contact time. KPMS at 10 mg/mL concentration reduced high
titers of FCV-F9 and MNV-1 by 1.92 and 1.56 log10 PFU/mL after 5 min, respectively; and
complete inactivation was obtained after 10 min and 15 min for FCV-F9 and MNV-1,
respectively. Lowering the concentration of KPMS to 5 mg/mL for 5 min of contact time only
resulted in a <1 log reduction for high titers of FCV-F9 and MNV-1. FCV-F9 at high titers were
reduced to undetectable levels after 10 min of exposure time to 5 mg/mL KPMS, while only 2.46
log10 PFU/mL reduction was reached for MNV-1 after 1 h at RT (Table 2.3a).

Reduction of FCV-F9 and MNV-1 by 0.32 mg/mL BAC in dirty coupon tests
The effect of BAC at 0.32 mg/mL concentration was decreased significantly on FCV-F9
and MNV-1 titer reduction after 1 or 2 h contact times under dirty conditions. Almost no
reduction was observed on high titers of FCV-F9 and MNV-1 after 2 h of contact time.
Furthermore, <0.5 log10 PFU/mL reduction was observed on low titers of FCV-F9 and MNV-1
after 1 or 2 h of exposure (Table 2.5).
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Reduction of FCV-F9 and MNV-1 by 5 and 10 mg/mL KPMS in dirty coupon tests
KPMS at 5 mg/mL for 2 min effectively inactivated low titers of FCV-F9 and reduced
MNV-1 to undetectable levels (Table 2.6). FCV-F9 at high titer was reduced to undetectable
levels after 15 min of exposure time by 5 mg/mL of KPMS. High titers of MNV-1 were reduced
by 2.29 logs after 1 h of contact time at RT, which was similar to the clean condition carrier
tests. Increasing the concentration of KPMS to 10 mg/mL reduced FCV-F9 and MNV-1 at low
titers to undetectable levels after 1 min and 30 s, respectively. High titers of FCV-F9 were
reduced to undetectable levels after 10 min. However, the effect of KPMS on high titers of
MNV-1 was decreased compared to the clean conditions, where only a 2.52 log10 PFU/mL
reduction was achieved after 15 min of contact time and complete reduction was observed only
after 1 h of exposure at RT (Table 2.3b).

Discussion
In this study, the effect of 0.32 mg/mL BAC and 5 and 10 mg/mL KPMS on the titer
reduction of FCV-F9 and MNV-1 was evaluated. The virus reduction was found to be related to
the contact time, contact surfaces, the type of virus and chemical disinfectant used. Generally,
longer contact times resulted in increased reductions for both tested viruses. BAC required
longer contact times to effectively inactivate both viruses, while KPMS was found to be a fastacting agent causing rapid reduction of viral titers within short contact times. Both chemicals had
decreased efficacy for both tested viruses using the stainless-steel coupon tests compared to
suspension tests that could be attributed to the interference of the physical properties of the
surface with contact between the microorganisms and disinfectants (Best et al., 1988). Not

60

surprisingly, the effect of both chemical disinfectants was decreased in the presence of organic
loads.
Current chemical disinfectants routinely used include alcohols including ethanol, 1propanol, and 2-propanol, glutaraldehyde and sodium hypochlorite. Using suspension tests, 70%
ethanol was most frequently tested by investigators, but without any conclusive suggestions on
its effectiveness against HNoV surrogates (Martino et al., 2010; Malik et al., 2006a; Park et al.,
2010; D’Souza and Su, 2010; Duizer et al., 2004; etc.). Iso-1-propanol at 50% and 70% was
reported to have >4 log reduction after 30 s of contact on FCV-F9, whereas 2-propanol was
effective only after 3 min of contact time (Gehrke et al., 2004). In another study, 1-propanol at
only 30% was shown to be the most effective virucidal agent among the three alcohols tested on
stainless steel for MNV-1 with 99.99% reduction, followed by (50-55%) ethanol and then (60%)
2-propanol (Magulski et al., 2009). Furthermore, this study showed the efficacy of 1000 ppm
peracetic acid and 2500 ppm glutaraldehyde to inactivate 99.99% of MNV on the carriers within
5 min of exposure time (Magulski et al., 2009). Using surface disinfection tests, 70% ethanol
was reported to be ineffective against high as well as low titers of MNV-1 and FCV-F9 after 1
min of contact time (D’Souza and Su, 2010). In comparison to ethanol, the results reported with
BAC show higher effects though requiring longer contact time of 1 h. Typical sodium
hypochlorite wash solutions were reported to be effective only at >300 ppm for HNoV
inactivation, where complete inactivation of FCV-F9 was reported at chlorine levels of 3,000
ppm (or higher) after 10 min at room temperature (Duizer et al., 2004). On the other hand, 2%
glutaraldehyde was found to effectively reduce FCV-F9 and MNV-1 by ~6 log10 PFU after 30 s
and 1 min of contact time, while 10% household bleach containing 5000 ppm free chlorine
resulted in effective reductions of FCV-F9 by >6 log10 PFU/mL in 1 min, but failed to
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completely inactivate MNV-1 (D’Souza and Su, 2010). These results are consistent with reports
showing that MNV-1 is a sturdy and resilient virus, resistant to most treatments and processing
conditions compared to FCV-F9. One surface disinfection test was carried out on fabrics and
carpets, to show that an activated dialdehyde-based product containing 2.6% glutaraldehyde
could reduce more than 99.99% of FCV in 1-10 min on all types of material tested (Malik et al.,
2006b).
Recently, Japanese investigators found that 1000 µg/mL copper iodide nanoparticles had
an extremely high antiviral activity reducing FCV by 7 orders of magnitude after 1 h of contact
time (Shionoiri et al., 2012). Furthermore, investigators suggested tannic acid derived from
Chinese medicinal herbs inhibited binding to histo-blood group antigens (HBGAs) receptors in
HNoVs, which indicated tannic acid a promising antiviral (Zhang et al., 2012). A novel MNV
strain, MT30-2, was isolated from the feces of mice in Japan and two antiseptics, povidoneiodine and sodium hypochlorite, revealed strong virucidal activity against MNV, which
inactivated MNV at low concentrations and in short exposure time (Matsuhira et al., 2012).
Quaternary ammonium compounds (QAC) have been studied as disinfectants against
human NoVs and its surrogates including FCV-F9 and MNV-1. Previous studies using
commercial cleansers that contain the active ingredient n-alkyl dimethyl benzyl ammonium
chloride at 0.08%, showed less than 1 log of reduction for MNV-1 was obtained after 10 min at
RT (Girard el at., 2010), and similar results were reported by others showing that QAC
disinfectants were not effective against FCV-F9 (Doultree et al., 1999; Eleraky el at., 2002).
Another commercial disinfectant with 1:10 final concentrations of QAC showed no reduction
against FCV after 1 min (Doultree et al., 1998). QAC disinfectants containing 0.14% BAC was
also shown to be ineffective at virolysis of human GII.4 norovirus (Nowak el at., 2011).
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Similarly, our study showed that both high and low titer of FCV-F9 and MNV-1 reached ≤1
log10 reduction by treatments with 0.32 mg/mL BAC after 10 min at RT, but required longer
exposure/contact times for improved effects.
BAC belongs to the QAC group, which have been widely utilized in hand sanitizers
(Moadab et al., 2001) and disinfectants for hard surfaces (Gradel et al., 2004) and as
pharmaceutical preservatives (Marple et al., 2004) due to its effectiveness in decontaminating a
broad spectrum of bacteria, viruses and fungi in solutions (Bastiani et al., 1974; Belec et al.,
2000; Jira et al., 1982). BAC at low concentrations is reported to be a non-irritant, non-toxic, and
non-corrosive to food contact surfaces and thus can be safely used as a disinfectant in the food
industry as a readily-used antimicrobial agent. However, studies showed that BAC requires
longer exposure time to inactivate non-enveloped viruses. Furthermore, in our study, longer
incubation times resulted in higher reduction irrespective of initial titers. Therefore, longer
contact times could be explored to estimate the effectiveness of BAC in decontaminating HNoV
surrogates. However, the long contact time of 1 h may not be suitable for all applications.
Recently, alternatives including trisodium phosphate (TSP) and hydrogen peroxide vapor
(HPV) are being studied as antiviral sanitizers. TSP at the concentrations of 1%, 2% and 5%
were tested on surfaces and produce. It appears to be suitable for titer reductions of FCV, MNV1 and MS2 bacteriophage on surfaces, and FCV and MNV-1 on produce. Studies showed that
higher concentration of TSP resulted in higher titer reduction with short contact times (30 s and 1
min) and 5% TSP achieved similar efficacy to 5000 ppm chlorine (D’Souza and Su, 2010; Su
and D’Souza, 2011). Though, the adverse effects of high concentrations of alkaline treatments
such as TSP on the environment, if any, may need to be explored. HPV appears to be a
promising virucide, showing that poliovirus, rotavirus, adenovirus and murine virus can be
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completely inactivated by 127 ppm HPV for 1 h at room temperature on stainless steel and
framing panel carriers (Tuladhar et al., 2012). Human norovirus GII.4 appeared to be most
resistant to HPV treatment, with a reduction of 0.5 log10 PCR units on stainless steel carriers.
Furthermore, their study indicated that low levels of feces (1%) did not significantly influence
the effectiveness of HPV (Tuladhar et al., 2012). However, the initial cost of the equipment to
generate HPV may be a limiting factor for some small scale industries or communities.
Therefore, other commonly used sanitizers and disinfectants need to be evaluated to
determine their effectiveness against human noroviruses. KPMS is widely used as a powerful
oxidizing agent. Currently, KPMS is routinely used in swimming pools against Escherichia
coli to keep the water clean and safe (Anipsitakis et al., 2008). It has also been used as a mist in
veterinary hospitals to decontaminate S. aureus and S. Typhiumurium by >99.9999% with the
concentration of 4% for 30 min exposure time after misting was completed (Patterson et al.,
2005). In a 6-year study, KPMS at concentrations of 1 and 10 mg/mL completely inactivated all
the bacteria-S. aureus, MRSA and Pseudomonas aeruginosa after 10 and 2 min exposure times,
respectively and no significant variation in resistance to KPMS was observed during the period
of study (Giacometti et al., 2002). However, only a few studies report the application of KPMS
for viral inactivation. The KPMS-based product Virkon S was shown to completely inactivate
the poultry enteric mortality syndrome (PEMS)-associated astrovirus in an embryo model, while
quaternary ammonium or benzalkonium chloride-based products had no effect against the virus
(Schultz-Cherry et al., 2001). Also, KPMS was shown to be effective against veterinary isolates
of FCV (Elarky et al., 2002).
In our study, KPMS at 5 mg/mL and 10 mg/mL reduced both viruses at low titers within
30 s and high titers of FCV-F9 after 2 min with 5 mg/mL while within 30 s with 10 mg/mL of
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KPMS to undetectable levels. High titers of FCV-F9 were reduced to undetectable levels after 2
min of treatment with 5 mg/mL KPMS. This is consistent with earlier research showing that
KPMS completely inactivated FCV after 10 min of exposure (Eleraky et al., 2002). However,
this study used only FCV from animal isolates and not the FCV-F9 strain or MNV-1. KPMS
appears to be a more suitable disinfectant among the tested chemicals. Though KPMS is fastacting, it could be corrosive to surfaces and equipment as a strong oxidative disinfectant, which
may not be proper for use in hand sanitizers. The applicability of KPMS as an alternative
strategy to decontaminate foodborne viruses on food contact surfaces (stainless steel) and under
soiled conditions was investigated in this study as well.
Solomon and others (2009) reported that 0.8 mg/mL QAC reduced FCV by 1.9 log10
PFU/mL after 10 min of exposure, while Virkon at 1% containing 5 mg/mL KPMS reduced FCV
from 4-5 log10 PFU/mL to undetectable levels after 10 min (Solomon et al., 2009). In
comparison, our results showed that 5 mg/mL KPMS reduced FCV from ~6 log10 PFU/mL to
undetectable levels after 2 min; and 0.32 mg/mL BAC decreased FCV at ~ 4 log10 PFU/mL by
1.9 log10 PFU/mL after 1 h. Su and D’Souza (2012) reported that BAC at 0.2, 0.5, and 1 mg/mL
reduced FCV-F9 and MNV-1 at low (~5 log10 PFU/mL) titers to undetectable levels after 2 h at
room temperature in suspension tests; and high (~7 log10 PFU/mL) titers of FCV-F9 were
reduced by 2.87, 3.08, and 3.25 log10 PFU/mL and high titers of MNV-1 were reduced by 1.55,
2.32, and 2.75 log10 PFU/mL, respectively. KPMS at 5, 10, and 20 mg/mL reduced high and low
titers of FCV-F9 and low titers of MNV-1 to undetectable levels, while high titers of MNV-1
were reduced by 0.92 and 3.44 log10 PFU/mL with KMPS at 5 and 10 mg/mL, respectively after
2 h at room temperature (Su and D’Souza, 2012). In comparison, our study showed that BAC at
0.32 mg/mL reduced FCV-F9 and MNV-1 at low (~5 log10 PFU/mL) titers by 1.94 and ≥3.14
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log10 PFU/mL after 1 h at room temperature in suspension tests, respectively; and FCV-F9 and
MNV-1 at high (~7 log10 PFU/mL) titers were decreased by 2.59 and 1.47 log10 PFU/mL,
respectively after 1 h. KPMS at 5 and 10 mg/mL reduced both low and high titers of FCV-F9
and MNV-1 to undetectable levels after 1 h
Since HNoV is transmitted via fecal-oral route, human excretions such as vomit and
stools can be the major sources of transmission of HNoV in the environment. Therefore, in
previous studies, simulated natural conditions have been carried out by adding organic
compounds into the virus stocks to determine the effect of disinfectants against HNoV and its
surrogates. In one study, investigators simulated field conditions using an organic acid, an
aldehyde, a halogen compound, and a peroxide as chemical disinfectants to show that the
efficacy of disinfectants against FCV and noroviruses could be greatly reduced in the presence of
organic impurities (25% feces) (Poschetto et al., 2007). However, another study showed that
organic loads (0.3% BSA plus 0.3% erythrocytes) did not change the effectiveness of the
biocides (Magulski et al., 2009). In our study, the effect of both chemicals against FCV-F9 and
MNV-1 decreased under simulated dirty conditions (5% FBS). BAC at 0.32 mg/mL reduced low
titers of FCV-F9 and MNV-1 by <0.5 log10 PFU/mL under dirty conditions, while undetectable
levels were achieved under clean conditions after 1 or 2 h exposure time at RT. Moreover, BAC
resulted in 1.45 and 1.05 log reductions against high titers of FCV-F9 after 1 and 2 h,
respectively, and ~0.7 log reduction against high titers of MNV-1 after 1 or 2 h under clean
conditions. However, almost no reduction of FCV-F9 and MNV-1 at high titers after 1 or 2 h
was observed under dirty conditions. The effect of KPMS at 5 and 10 mg/mL was diminished
somewhat in the presence of organic loads where 5 mg/mL of KPMS reduced FCV-F9 and
MNV-1 at low titers to undetectable levels within 30 s and after 2 min under clean and dirty
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conditions, respectively. KPMS at 10 mg/mL showed no difference against FCV-F9 at both high
and low titers and MNV-1 at low titer under clean or dirty conditions; however, effects
significantly decreased against high titers of MNV-1, resulting in complete inactivation after 15
min and 1 h under clean and dirty conditions, respectively.
Conclusion
This study provides data on alternative methods for HNoV surrogate reduction. Further
studies using higher concentrations of BAC may be necessary to determine the efficacy of its
antiviral effects against HNoV surrogates for use in food processing, hospital or industrial
settings. Our results with KPMS show its strong potential for application in decontaminating
enteric viruses in a rapid and effective manner, though caution is advised as it is a strong
oxidizing agent.
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Table 2.1: Reduction of low and high titers of FCV-F9 and MNV-1 at room temperature by 0.32 mg/mL benzalkonium chloride (BAC)
using suspension tests.
FCV-F9 (log10 PFU/mL) at Low
titer

Contact time
(min)

Recovered titer

Control

4.66±0.13A

5

Reduction

MNV-1 (log10 PFU/mL) at Low
titer

FCV-F9 (log10 PFU/mL) at High
titer

Reduction

MNV-1 (log10 PFU/mL) at High
titer

Recovered titer

Reduction

Recovered titer

Recovered titer

Reduction

0.00

4.41±0.17A

0.00

6.42±0.14A

0.00

6.24±0.06A

0.00

4.10±0.17B

0.56

4.09±0.25AB

0.32

5.76±0.09B

0.66

5.40±0.31AB

0.84

10

4.04±0.06B

0.62

3.84±0.21BC

0.57

5.39±0.08C

1.03

5.33±0.32AB

0.91

15

3.85±0.15BC

0.81

3.68±0.24CD

0.73

5.16±0.09C

1.26

5.01±0.36B

1.23

30

3.55±0.09C

1.11

3.35±0.12D

1.06

4.43±0.10D

1.99

4.93±0.46B

1.31

60

2.73±0.25D

1.94

<10E

≥3.41*

3.83±0.09E

2.59

4.77±0.39B

1.47

Different letters denote significant differences when compared within each column alone (p<0.05).
*Indicates inactivation values at the detection limit of the assay since BAC fixed the cell monolayers after 1 log serial dilution but not
the lower dilution of the virus-treatment combination.
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Table 2.2: Reduction of FCV-F9 and MNV-1 at high titers by potassium peroxymonosulfate (KPMS) at 5 and 10 mg/mL at room
temperature in suspension tests.
FCV-F9 (log10 PFU/mL) with 5
mg/mL KPMS
Contact
time
(min)
Control

Recovered titer

Reduction

MNV-1 (log10 PFU/mL) with 5
mg/mL KPMS

FCV-F9 (log10 PFU/mL with 10
mg/mL KPMS

MNV-1 (log10 PFU/mL) with 10
mg/mL KPMS

Recovered titer

Recovered titer

Reduction

Recovered titer

Reduction

Reduction

6.41±0.15A

0.00

6.45±0.12A

0.00

6.00±0.08A

0.00

6.16±0.07A

0.00

0.5

3.71±0.06B

2.70

6.04±0.10B

0.41

<10B

≥5.00*

3.98±0.10B

2.18

1

2.10±0.19C

4.31

5.87±0.20B

0.58

<10B

≥5.00*

2.91±0.15C

3.25

2

<10D

≥5.41*

5.98±0.05B

0.47

<10B

≥5.00*

2.48±0.16D

3.68

5

<10D

≥5.41*

5.97±0.09B

0.48

<10B

≥5.00*

1.55±0.23E

4.61

Different letters denote significant differences when compared within each column alone (p<0.05).
*Indicates inactivation values at the detection limit of the assay since KPMS fixed the cell monolayers after the first-log serial dilution
but not the lower dilutions of the virus-treatment combination.

74

Table 2.3: Reduction of FCV-F9 and MNV-1 at high titers on clean (a) and dirty (b) sterile stainless-steel coupons (carrier tests) by 5
mg/mL and 10 mg/mL potassium peroxymonosulfate (KPMS) at room temperature.
a.
FCV-F9 (log10 PFU/mL) with 5
mg/mL KPMS
Contact
time (min)
Control

Recovered titer
7.51±0.08

A

Reduction

MNV-1 (log10 PFU/mL) with 5
mg/mL KPMS
Recovered titer

0.00

5.83±0.07

A

Reduction
0.00

FCV-F9 (log10 PFU/mL) with 10
mg/mL KPMS

MNV-1 (log10 PFU/mL) with 10
mg/mL KPMS

Recovered titer

Recovered titer

7.51±0.08

A

Reduction

Reduction

0.00

5.83±0.07

A

0.00

0.5

7.25±0.06AB

0.26

5.79±0.03A

0.04

6.36±0.07B

1.15

5.02±0.18B

0.81

1

6.95±0.09B

0.56

5.69±0.07AB

0.14

6.40±0.05B

1.11

5.12±0.04B

0.71

2

6.86±0.11B

0.65

5.58±0.13B

0.25

5.70±0.18B

1.81

4.44±0.08B

1.39

5

7.03±0.14B

0.48

5.16±0.09C

0.67

5.59±0.40B

1.92

4.27±0.23B

1.56

10

<10C

≥6.51*

4.19±0.06B

1.64

<10C

≥6.51*

3.11±0.06B

2.72

15

<10C

≥6.51*

4.18±0.10B

1.65

<10C

≥6.51*

<10C

≥4.83*

30

<10C

≥6.51*

3.63±0.12C

2.20

<10C

≥6.51*

<10C

≥4.83*

60

<10C

≥6.51*

3.37±0.21C

2.46

<10C

≥6.51*

<10C

≥4.83*

Different letters denote significant differences when compared within each column alone (p<0.05).
*Indicates inactivation values at the detection limit of the assay since KPMS fixed the cell monolayers after the first-log serial dilution
but not the lower dilutions of the virus-treatment combination.
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Table 2.3: Reduction of FCV-F9 and MNV-1 at high titers on clean (a) and dirty (b) sterile stainless-steel coupons (carrier tests) by 5
mg/mL and 10 mg/mL potassium peroxymonosulfate (KPMS) at room temperature (Continued).
b.
FCV-F9 (log10 PFU/mL) with 5
mg/mL KPMS
Contact
time (min)
Control
10

Recovered titer

Reduction

MNV-1 (log10 PFU/mL) with 5
mg/mL KPMS
Recovered titer

0.00

5.85±0.09

2.71±0.08B

5.27

4.59±0.03B

1.26

7.98±0.03

A

Reduction

A

0.00

FCV-F9 (log10 PFU/mL) with 10
mg/mL KPMS

MNV-1 (log10 PFU/mL) with 10
mg/mL KPMS

Recovered titer

Recovered titer

Reduction

Reduction

0.00

5. 85±0.09

A

0.00

<10B

≥6.98*

3.51±0.09B

2.34

7.98±0.03

A

15

<10C

≥6.98*

4.43±0.09BC

1.42

<10B

≥6.98*

3.33±0.06B

2.52

30

<10C

≥6.98*

4.26±0.02C

1.59

<10B

≥6.98*

2.83±0.13C

3.02

60

<10C

≥6.98*

3.56±0.13D

2.29

<10B

≥6.98*

<10C

≥4.85*

Different letters denote significant differences when compared within each column alone (p<0.05).
*Indicates inactivation values at the detection limit of the assay since KPMS fixed the cell monolayers after the first-log serial dilution
but not the lower dilutions of the virus-treatment combination.
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Table 2.4: Reduction of FCV-F9 and MNV-1 at high titers on clean sterile stainless-steel coupons
by 0.32 mg/mL BAC at room temperature.
FCV-F9 (log10 PFU/mL)

MNV-1 (log10 PFU/mL)

Contact time
Recovered titer

Reduction

Recovered titer

Reduction

Water 1 h

7.88±0.05A

0.00

5.60±0.12A

1h

6.43±0.08B

1.45

4.84±0.11BC

0.76

Water 2 h

6.78±0.32B

0.00

5.41±0.33AB

0.00

2h

5.73±0.05C

1.05

4.71±0.24C

0.70

0.00

Different letters denote significant differences when compared within each column alone
(p<0.05).
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Table 2.5: Reduction of FCV-F9 and MNV-1 at high and low titers on sterile stainless-steel coupons with 5% FBS (dirty condition) by
0.32 mg/mL BAC at room temperature.
FCV-F9 (log10 PFU/mL) at Low

MNV-1 (log10 PFU/mL) at Low

FCV-F9 (log10 PFU/mL) at High

MNV-1 (log10 PFU/mL) at High

titer

titer

titer

titer

Contact time
Recovered titer

Reduction

Recovered titer

Reduction

Recovered titer

Reduction

Recovered titer

Reduction

Water 1 h

6.03±0.02A

0.00

4.38±0.07A

0.00

8.14±0.06A

0.00

5.90±0.08A

0.00

1h

5.85±0.18AB

0.18

4.17±0.06B

0.21

8.14±0.03A

0.00

5.01±0.04C

0.89

Water 2 h

6.10±0.03A

0.00

4.40±0.08A

0.00

8.19±0.05A

0.00

5.99±0.06A

0.00

2h

5.56±0.11B

0.54

3.94±0.08C

0.46

8.01±0.02B

0.18

5.62±0.02B

0.36

(min)

Different letters denote significant differences when compared within each column alone (p<0.05).

78

Table 2.6: Reduction of FCV-F9 and MNV-1 at low titers on dirty carrier tests by 5 and 10 mg/mL potassium peroxymonosulfate
(KPMS) at room temperature.
FCV-F9 (log10 PFU/mL) with 5
mg/mL KPMS
Contact
time (min)
Control

Recovered titer

Reduction

MNV-1 (log10 PFU/mL) with 5
mg/mL KPMS
Recovered titer

0.00

3.67±0.09

0.5

4.09±0.06B

1.94

1.76±0.31B

1.91

1

3.72±0.04C

2.31

1.46±0.22B

2.21

2

<10C

≥5.03*

<10C

≥2.67*

6.03±0.07

A

Reduction

A

0.00

FCV-F9 (log10 PFU/mL) with 10
mg/mL KPMS

MNV-1 (log10 PFU/mL) with 10
mg/mL KPMS

Recovered titer

Recovered titer

Reduction
0.00

3.67±0.09

2.43±0.09B

3.50

<10B

≥2.67*

<10C

≥4.93*

<10B

≥2.67*

<10C

≥4.93*

<10B

≥2.67*

5.93±0.09

A

Reduction

A

0.00

Different letters denote significant differences when compared within each column alone (p<0.05).
*Indicates inactivation values at the detection limit of the assay since KPMS fixed the cell monolayers after the first-log serial dilution
but not the lower dilutions of the virus-treatment combination.
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Abstract
Sodium metasilicate is USDA FSIS approved as a processing aid for meat and poultry
products with known antibacterial properties and anti-rotaviral activity. However, its efficacy
against human noroviruses, the leading cause of non-bacterial gastroenteritis, has not been
reported. Concentration-dependent effects of sodium metasilicate at 2%, 5%, and 10% against
cultivable human norovirus surrogates, (feline calicivirus (FCV-F9) and murine norovirus
(MNV-1)), at room temperature for up to 1 h using both suspension and carrier tests were
evaluated. Each virus at high (6~8 log10 PFU/mL) or low (4~6 log10 PFU/mL) titers was mixed
with equal volumes of sodium metasilicate and incubated for 15 s, 30 s, 1 min, 2 min, 5 min, 10
min, 15 min, 30 min and 1 h. Each treatment was replicated thrice, recovered viruses were
plaque assayed in duplicate, and data was statistically analyzed. Virus reduction by 5 and 10%
sodium metasilicate was rapid, with complete reduction within 15 s for both tested viruses at
both titers using suspension tests. FCV-F9 and MNV-1 at high titers were reduced to
undetectable levels with 2% sodium metasilicate after 2 min and 15 s, respectively; with
complete reduction of both viruses at low titers within 15 s. For carrier tests, under dry
conditions, complete reduction of FCV-F9 at high titers was achieved by 2 and 5% sodium
metaslicate after 10 min and 15 s, respectively; high titers of MNV-1 were reduced to
undetectable levels by 2% sodium metasilicate after 2 min; and complete reduction of both tested
viruses at low titers were observed within 15 s. This research shows the potential application of
the processing aid sodium metasilicate as a 2% solution for the control of human norovirus
transmission.
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Introduction
Human noroviruses are non-enveloped, single-stranded RNA viruses that belong to the
Caliciviridae family. They are currently considered the leading cause of foodborne illness
outbreaks worldwide. In the United States, over half of the foodborne disease outbreaks reported
by the Centers for Disease Control and Prevention from 2006 to 2008 were attributed to human
noroviruses (Scallen et al., 2011; Siebenga et al., 2009; CDC, 2011). The difficulty involved in
controlling human norovirus outbreaks are due to their ease of transmission, high attack rates,
environmental stability and low infectious doses of 10 to 100 viral particles (Caul, 1994;
D'Souza et al., 2006; Liu et al., 2009). The virus can be transmitted by person to person, or via
the fecal-oral route (Goodgame et al., 2006). In addition, people may be infected by consuming
contaminated food or water and touching inanimate objects contaminated with the virus.
Outbreaks have occurred in a variety of closed settings, including long-term care and other
healthcare facilities, restaurants and catered events, cruise ships, schools, hotels, and other
institutional settings and also involve ready-to-eat food items that do not undergo further
processing before consumption (CDC, 2011). The symptoms include nausea, vomiting, diarrhea
and abdominal pain. Although the infection is self-limiting, the emerging virulent strains can be
life-threatening to the elderly and the immuno-compromised (Siebenga et al., 2009; Donaldson et
al., 2010). Routine sanitation and hygienic practices need to be followed to prevent outbreaks.
Commonly used sanitizers including chlorine containing compounds have been found to be
efficacious for surface decontamination (D’Souza and Su, 2010).
Sodium metasilicate is a commonly used USDA FSIS approved processing aid in the
food industry that is highly soluble with the pH of a 1% solution ranging from 12.5 to 13.0
(Sharma et al., 2012a). It is approved for use as an antimicrobial component of marinades for
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meat and poultry products at up to 2% by weight of the marinades and also as a carcass rinse or
spray on raw beef carcasses, subprimals, and trimmings at up to 6% in solutions (USDA FSIS,
2011). Sodium metasilicate has been shown to be effective against foodborne bacterial pathogens
including Escherichia coli O157: H7 and Salmonella species both in vitro and in beef trimmings
(Carlson et al., 2008; Geornaras et al., 2012; Pohlman et al., 2007; Weber et al., 2004), and also
Campylobacter jejuni and Salmonella Typhimurium in fresh chicken breast meat (Sharma et al.,
2012a, b). Weber et al. (2004) found that sodium metasilicate at 0.6% (pH 12.1) resulted in
complete inhibition of E. coli O157: H7 after a 5 to 10 s exposure in water at room temperature
(Weber et al., 2004). Carlson et al., (2008) reported that 4% sodium metasilicate (23oC, pH
12.94) reduced E. coli O157: H7 and Salmonella by ~1.9 and ~ 2.6 log CFU/mL, respectively
from inoculated beef hides following a 30 s- spray- 2 min- dwell- 30 s - water rinse procedure
(Carlson et al., 2008). Pohlman et al. (2009) demonstrated that E. coli and Salmonella
Typhimurium were reduced by ~1 log to ≥1.5 log CFU/mL, respectively, after treatment with
4% sodium metasilicate on inoculated beef trimmings (Pohlman et al., 2009). Geornaras et al.
(2012) found similar effectiveness of sodium metasilicate against E.coli O157:H7 and 6 nonO157 Shiga toxin-producing E. coli (nSTEC) serogroups. After immersion for 30 s in a solution
of 4% sodium metasilicate (pH 12.5), initial pathogen counts were found to be reduced by 1.3 to
1.5 log CFU/cm2 on inoculated beef trimmings from an initial count of 3 to 4 log CFU/cm2
(Geornaras et al., 2012). Adler et al. (2011) observed that brine solution containing 2.2% sodium
metasilicate immediately reduced E.coli O157:H7 by ≥2.4 log CFU/mL at 4 or 15 oC(Adler et
al., 2011).
Besides these foodborne bacterial pathogens, sodium metasilicate has also been evaluated
for its efficacy against viral pathogens, including human rotaviruses and vesicular stomatitis
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viruses (Springthorpe et al., 1986; Wright 1970). Springthorpe et al. (1986) tested the efficacy of
69 commercial and 7 non-commercial disinfectant formulations against human rotaviruses and
found that the efficacy of quaternary ammonium-based disinfectant formulations was greatly
improved by adding 0.5 to 5% sodium metasilicate, being effective against human rotaviruses.
They believed that quaternary ammonium compounds and sodium metasilicate may act in an
additive or synergistic manner to inactivate human rotaviruses (Springthorpe et al., 1986).
However, information is currently lacking on the antiviral activity of sodium metasilicate against
human norovirus surrogates in vitro. The objective of this study was to determine the ability of
2%, 5%, and 10% sodium metasilicate to inactivate human norovirus surrogates, FCV-F9 and
MNV-1, in suspension and using carrier tests (stainless steel coupons) at room temperature.

Materials and Methods
Virus stocks and cell lines: Feline calicivirus (FCV-F9) and its host, Crandell Reese
Feline Kidney (CRFK) cells, were obtained from American type culture collection (ATCC)
(Manassas, VA). Murine norovirus (MNV-1) was kindly provided by Dr. Skip Virgin
(Washington University, St. Louis, MO), and its host, RAW 264.7 cells were obtained from the
University of Tennessee cell culture collection. Viral stocks containing ~6 log10 PFU/mL of
MNV-1 and ~8 log10 PFU/mL of FCV-F9 were obtained as previously described using their
respectively confluent cell lines in 175cm2 flasks (D’Souza et al., 2011; Su et al., 2011).
Chemicals: Sodium metasilicate obtained from MP Biomedicals (Solon, OH, USA) was
dissolved in de-ionized water and then filtered through 0.2μm filters (Fisher Scientific, GA,
USA) to reach concentrations of 10% (w/v), 5% (w/v), and 2% (w/v).
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Treatments: For suspension tests, one volume (167μl) of sodium metasilicate was
mixed with the same volume of virus to reach final concentrations of 5% (w/v), 2.5% (w/v), and
1% (w/v) and incubated for 15 s, 30 s, 1 min, 2 min, 5 min, 10 min, 15 min, 30 min and 1 h at
room temperature. Sterile de-ionized water was used as a control to compare with the treated
samples. At each time point, treatments were neutralized by serially diluting in Dulbecco’s
Modified Eagle’s Medium/Ham’s F-12 (DMEM, HyClone Laboratories, Inc, Logan, Utah)
containing 10% heat-inactivated Fetal Bovine Serum (FBS, HyClone Laboratories, Inc, Logan,
Utah), followed by serial dilutions in DMEM containing 2% heat-inactivated FBS.
For the carrier test, stainless steel coupons sterilized by autoclaving were used as a
surface model (fomite) to simulate natural conditions. MNV-1 and FCV-F9 were inoculated on
sterile coupons at high and low titers and allowed to dry for 1 h at room temperature in a
BioSafety Level 2 hood. After drying, the coupons were treated with 2% sodium metasilicate for
various time intervals from 0, 15 s, 30 s, 1, 2, 5, 10, 15, 30 and 60 min at room temperature (RT).
Plaque Assays: Treated samples and controls were inoculated onto the confluent CRFK
cells for FCV-F9 and RAW 267.4 cells for MNV-1 in 6-well plates, and incubated for 2.5 h at 37
℃ under 5% CO2. Then overlay media containing 0.75% (w/v) noble agar was added to each
well and incubated for 2 to 3 days at 37℃ in a CO2 incubator. Finally, neutral red (SigmaAldrich, St. Louis, MO) containing overlay media was added and incubated for 3 to 24 h to
visualize the plaques.
Statistical Analysis: All treatments and controls were replicated three times in
duplicates. A one-way analysis of variance (ANOVA) was used to test for differences in means
of plaque counts among treatments and means were analyzed using a completely randomized
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design at p<0.05 in SAS program (version 9.3, SAS Institute, Cary, NC, USA). If statistically
significant differences were found using the ANOVA, the Tukey’s Post Hoc test was used to
analyze differences in means between treatments.
Results
Effect of 5 and 10% sodium metasilicate against FCV-F9 and MNV-1 at high and
low titers in suspension tests: Both 5 and 10% sodium metasilicate reduced high and low titers
of FCV-F9 and MNV-1 to undetectable levels within 15 s at room temperature (data not shown).
Effect of 2% sodium metasilicate against FCV-F9 and MNV-1 in suspension tests:
Sodium metaslicate at 2% reduced FCV-F9 at low titers and MNV-1 at both high and low titers
to undetectable levels within 15 s at room temperature. The reduction caused by 2% sodium
metasilicate on high titers of FCV-F9 in suspension tests are shown in Table 3.1. FCV-F9 at high
titers were reduced by 5.42, 6.02, and 6.18 log PFU by 2% sodium metasilicate after 15 s, 30 s,
and 1 min, respectively; and complete reduction was observed after 2 min contact time at room
temperature.
Effect of 2% sodium metasilicate against FCV-F9 and MNV-1 in carrier tests: Low
titers of FCV-F9 and MNV-1 were reduced to undetectable levels within 15 s at room
temperature using stainless steel coupons. The effects of 2% sodium metasilicate on high titers of
FCV-F9 and MNV-1 in carrier tests are shown in Table 3.2. Compared to the titer reduction of
the tested viruses at high titers in suspension tests, the titer reduction of FCV-F9 and MNV-1 in
carrier tests appeared to be slightly lower, where 2% sodium metasilicate decreased the FCV-F9
at high titers by 2.28, 3.19, 3.59 and 4.80 log10 PFU/mL, respectively after 30 s, 1 min, 2 min and
5 min of exposure time. High titers of MNV-1 were decreased by 1.04 and 2.02 log10 PFU/mL
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after 30 s and 1min, respectively with 2% sodium metasilicate. FCV-F9 and MNV-1 were
reduced to non-detectable limits (based on the detection limit of the plaque assays 1 log10
PFU/mL) by 2% sodium metasilicate after 10 min and 2 min of contact times at room
temperature, respectively.
Discussion
In the present study, the effect of sodium metasilicate at concentrations of 2%, 5%, and
10% on inactivation of FCV-F9 and MNV-1 was evaluated. Sodium metasilicate was found to
cause rapid reduction in titers of the tested human noroviral surrogates. FCV-F9 and MNV-1 at
low titers were reduced to undetectable levels within 15 s by 2% sodium metasilicate in both
suspension and carrier tests at room temperature. Complete reduction of FCV-F9 and MNV-1 at
high titers was achieved by 2% sodium metasilicate after 2 min and within 15 s in suspension
tests, respectively. In carrier tests, high titer FCV-F9 and MNV-1 were reduced to undetectable
levels after 10 min and 2 min at room temperature, respectively. Increasing the concentrations of
sodium metasilicate to 5 and 10% were found to reduce FCV-9 and MNV-1 at high titers to
undetectable levels within 15 s in both suspension and carrier tests. The results revealed the
potential suitability of using sodium metasilicate to prevent the transmission of human noroviral
outbreaks.
Chemicals other than sodium metasilicate used include trisodium phosphate (TSP), a
common household cleanser, which is also an alkaline detergent with the pH of 12 in 1%
solution, and considered as GRAS by the FDA (Lindsay 1985). TSP is reported to be effective
against a wide range of pathogens, including E. coli O157: H7, Salmonella, Poliovius 1 and
bacteriophages. Jerzy and others (2003) reported that significant reductions of bacteriophage
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MS2 and poliovirus1 were obtained using 1.0% TSP solution on strawberries (Jerzy et al., 2003).
D’Souza and Su (2010) reported that 5% TSP effectively inactivated high titers of MNV-1 and
FCV-F9 by ≥6 log PFU/mL, and with ~ 5 log reduction of low viral titers after 30s or 1 min
contact time. TSP at 2% were found to inactivate high titers of FCV-F9 by ≥6 log PFU/mL, but
only a 1.05 log reduction for MNV-1 after 1 min was obtained. TSP at 1% was also reported to
reduce FCV-F9 by ~2.65 log PFU/mL, while no reduction was observed for high titers of MNV1 (D'Souza and Su, 2010). In this study, sodium metasilicate at the lower concentrations of 2%
appears to be more effective than TSP for the titer reduction of these human noroviral surrogates.
The mechanism of antibacterial activity of TSP is believed to be due to a combination of
high pH (~12), ionic strength and detergent effects that can cause cell wall and membrane
disruption of Gram-negative foodborne pathogens (Mendonca et al., 1994; Sampathkumar et al.,
2003; Yuk and Marshall, 2006). However, the mechanism of virucidal activity has not been
elucidated. The mechanism of antimicrobial effect of sodium metasilicate could be similar to
TSP in that they are both strongly alkaline. Further research is needed to explore the antiviral
mechanism of action.
The application of sodium metasilicate in food industry can be broader than TSP, as
sodium metasilicate has been approved to be directly added in food as a processing aid to wash
fruits, vegetables, and nuts. It can also be applied in poultry and meat products as an
antimicrobial (US FDA 2003). Furthermore, previous studies have shown that sodium
metasilicate can maintain the quality of fresh commercial poultry, having no negative effects on
sensory, physical or chemical characteristics. These investigators found that 1-4% sodium
metasilicate did not adversely affect sensory characteristics, color, texture or pH of fresh
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commercial chicken breast meat at 4oC after 9 days (Huang et al., 2011). Pohlman et al., (2009)
also reported little impact of sensory odor and color characteristics was observed by 4% sodium
metasilicate in beef trimmings (Pohlman et al., 2009). Additionally, Quilo et al. (2010) revealed
that better quality were perceived by using 4% sodium metasilicate in beef trimmings, resulting
in much juicier, lower Warner-Bratzler shear force value for texture, and less cooking loss than
the control samples (Quilo et al., 2010).
Besides alkaline chemical treatments, acidic solutions, including lactic acid and
peroxyacetic acid, also have a long history of commercial use for the inactivation of foodborne
pathogens. The mode of action of these organic acids and its salts on foodborne bacteria
pathogens appears to be the result of the diffusion of the undissociated form of the acid into the
cell, leading to decreasing intracellular pH. In order to sustain the pH inside the cell, ATPase
pumps out protons at the expense of ATP. Eventually, cells die due to the lack of cellular energy
(Bogaert and Naidu, 2000). The acid mediated mechanisms leading to a loss of infectivity of
foodborne viruses has not been completely understood, which is believed to result from the
alterations of the virus capsid and nucleic acid (Cliver, 2009; Salo and Cliver, 1976). However,
whether the effect was derived from the decrease in pH or the type of acid is still not clear. It is
appeared that the inactivation of non-enveloped viruses is due to the denaturation of the capsid
proteins due to the decrease in pH (Rodger et al., 1977).
Previous research has shown the effect of lactic acid and peroxyacetic acid against human
norovirus surrogates. Using suspension tests, Straube et al., (2011) found that D, L-lactic acid at
the concentration of 0.3% (pH 3.4-3.5) and 0.4% (pH 3.2-3.3) could reach a significant titer
reduction of FCV-F9 after 7 days at 20°C (Straube et al., 2011). Baert et al., (2009) reported that
the application of 250 mg/L peroxyacetic acid to washing solution could obtain a supplementary
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1-log reduction of MNV-1 on shredded iceberg lettuce (compared to tap water), and its efficacy
was not influenced by the presence of organic materials (Baert et al., 2009). Fraisse et al., (2011)
found that 100 ppm of peroxyacetic-based biocide effectively inactivated FCV-F9 by 3.2 log
units and MNV-1 by 2.3 log units on the lettuce leaves after 2 min of contact time, as estimated
by cell culture (Fraisse et al., 2011).
Other effective cleansers, including chlorine have been commonly used to disinfect
foodborne pathogens. Chlorine has been tested for antiviral activity against human norovirus
surrogates and found to be very effective in inactivating FCV-F9 and MNV-1 in suspension, on
surfaces, and on produce (Belliot et al., 2008; D'Souza and Su, 2010; Doultree et al., 1999;
Duizer et al., 2004; Fraisse et al., 2011; Kitajima et al., 2010; Urakami et al., 2007). However,
due to the corrosive nature of chlorine, bleaching of food and unfavorable sensory effects, it has
limitations for use. Furthermore, by-products including trihalomethanes may be generated due to
interaction with organic matters, which can cause carcinogenic products and potential risks to
public health (Dunnick and Melnick, 1993). Overall, based on the findings of this study, sodium
metasilicate may be suitable and applicable for the food industry to decrease foodborne human
noroviral transmission risk.
Conclusion
Sodium metasilicate at 2% is found to be very suitable for inactivating human norovirus
surrogates, FCV-F9 and MNV-1 in both suspension and carrier tests, indicating its potential use
as an antiviral component for surface disinfection or could be potentially used in marinades. This
chemical is already approved as a processing aid in meat and poultry products and being fastacting has great promise to reduce human norovirus surrogate transmision. The application of
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sodium metasilicate as an alternative coating or strategy to decontaminate foodborne viruses in
foods, such as meat and fresh produce, needs to be investigated.
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Table 3.1: The effect of sodium metasilicate at 2% on reduction of FCV-F9 at high titer using
suspension tests at room temperature.

FCV-F9 (log10 PFU/mL)
Contact time
Recovered titer

Reduction

Control

7.86±0.08A

0.00

15 s

2.45±0.16B

5.41

30 s

1.84±0.34BC

6.02

1 min

1.68±0.23C

6.18

2 min

<10D

≥6.86*

5 min

<10D

≥6.86*

Different letters denote significant differences when compared within each column alone
(p<0.05).
*Indicates inactivation values at the detection limit of the assay since sodium metasilicate fixed
the cell monolayers after the first-log serial dilution but not the lower dilutions of the virustreatment combination.
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Table 3.2: The effect of sodium metasilicate at 2% on reduction of FCV-F9 and MNV-1 at high
titers using carrier tests at room temperature.

FCV-F9 (log10 PFU/mL)

MNV-1 (log10 PFU/mL)

Contact time
Recovered titer

Reduction

Recovered titer

Reduction

Control

7.97±0.08A

0.00

5.74±0.11A

0.00

30 s

5.69±0.17B

2.28

4.70±0.04B

1.04

1 min

4.79±0.12C

3.18

3.72±0.06C

2.02

2 min

4.38±0.16D

3.59

<10D

≥4.74*

5 min

3.17±0.15E

4.80

<10D

≥4.74*

10 min

<10F

≥6.97*

<10D

≥4.74*

15 min

<10F

≥6.97*

<10D

≥4.74*

Different letters denote significant differences when compared within each column alone
(p<0.05).
*Indicates inactivation values at the detection limit of the assay since sodium metasilicate fixed
the cell monolayers after the first-log serial dilution but not the lower dilutions of the virustreatment combination.

98

Vita
Cong Cao was born in Zhejiang, China on September 14, 1988. She grew up in the main
island of Zhoushan Islands and graduated from Zhoushan High School in 2007. She continued
her education at Hunan Agricultural University where she earned a B.S. degree majoring in Food
Science and Engineering in 2011. In 2013, she earned an M.S degree in Food Science and
Technology from the University of Tennessee, Knoxville.

99

